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Until recently, the national implementation of a public sector Antiretroviral Therapy 
(ART) programme in South Africa seemed financially impossible. Drastically reduced prices 
for Antiretrovirals (ARVs) combined with substantial donor funding and the long-awaited 
adoption of a national treatment plan, have, however, shifted the debate. Now the question is 
not so much should universal ART be provided by government but, rather, is it possible to 
implement in severely resource-constrained environments and, if so, what are the best ways 
to deliver these services. 
The Western Cape public sector ART programme serves as an innovative case study 
from which to examine this question. In this province, the provincial government launched 
South Africa's first government-run programme to prevent mother-to-child transmission 
(PMTCT) of HI V in 1999, and expanded this in 2001 to include ART, making the project the 
first to use ARV s in government health facilities outside the context of clinical trials. 
Moreover, in 2004, the pilot ART project was scaled-up throughout the province. It is 
considered to be a highly effective and successful programme. By December 2005, it was 
estimated that 55.7% of people that' need ART in the province had access to it as compared to 
a national average of 10% for South Africa. 
At the forefront of ART programmmg, the Western Cape Province provides an 
important example for the rest of the country on how to successfully scale up HIV/AIDS 
treatment programmes. It also serves as a pioneering illustration to the global community 
that the use of ARV s at primary care level in resource-constrained settings is feasible, 
affordable and replicable. Furthermore, it offers insights into persisting bottlenecks and 
barriers confronting the rapid roll-out of HIV treatment, the achievement of national targets, 
and, most importantly, the goal of ensuring long-term universal and, thus, equitable access. 
As such, drawing from existing literature as well as interviews with key stakeholders, this 
study examines the factors that have ensured the successful provision and expansion of the 
ART programme in the Western Cape, as well as the challenges of expanding coverage 
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Despite countless interventions, HIV I AIDS 1 continues to nse in nearly every region 
across the globe. 2005 witnessed the highest number of people living with the virus, an estimated 
38.6 million [33.4 million-46.0 million], with over four million people newly infected in the last 
year (UNAIDS, 2006). Sub-Saharan Africa remains the worst affected region and is home to 
almost two-thirds of all people, and 77% of all women, living with HIV (UNAIDS, 2005). In 
South Africa, a history of oppression, social disenfranchisement, the migrant labour system and 
poverty have contributed to the spread of the epidemic with estimated adult prevalence rates of 
18.8% [16.8%-20.7%] within a general population of 47.43 million (UNAIDS, 2006). In 
addition, South Africa continues to have the highest number of people living with HIV in the 
world estimated at 5.5 million [4.9 million-6.1 million] (ibidi. An analysis of death registration 
data shows a substantial rise in the total number of adult deaths in the past six years -- an 
increase of more than 40% and, for women aged 20-49 years, an increase of more than 150% 
taking into account population growth and improvements that have been made in the 
registrations of deaths (Bradshaw, 2004). 
Within this context, there has been a widespread movement advocating for universal 
access to affordable, quality and lifesaving HIV/AIDS drugs as a critical component in 
addressing the spread and impact of HIV/AIDS. Antiretroviral Therapy (ART)3 has been shown 
to make a dramatic difference in the health and survival of People Living with HIV I AIDS 
(PL WHA), prolonging their lives as active citizens (Farmer et aI., 2001; Schneider & Coetzee, 
2003; Coetzee et al., 2004a). Specifically, ART has been shown to cause a dramatic drop in the 
1 Commonly denoted merely as these acronyms, HIV stands for the Human Immunodeficiency Virus and 
AIDS is the Acquired Immune Deficiency Syndrome. 
2 There has been much debate concerning the accuracy of the UNAIDS models and their underlying 
assumptions. Using a larger number of variables and inputs, the ASSA Interventions Models engineered 
at the University of Cape Town have historically estimated prevalence rates as well as PL WHA in South 
Africa to be somewhat lower. Until 2005, these projections have been more in line with provincial and 
national estimations suggesting the models' greater accuracy (Abdullah, 2005a; Bourne, 2005; Dorrington 
et at., 2004). However, in the last year, UNAIDS estimates now have confidence intervals as noted above 
allowing for these discrepancies in modelling and these now match the national Department of Health 
estimates (DOH, 2006a). 
3 Antiretroviral Therapy (ART) is also known as Highly Active Antiretroviral Therapy (HAART). I will 

















number of opportunistic infections and the consequent number of hospital admissions (Farmer et 
al., 2001; Nattrass, 2004). Research has also demonstrated that when HIV/AIDS treatment 
programmes are available, accessible and culturally-acceptable to communities, participation in 
Voluntary Counselling and Testing (VCT) increases (Nattrass, 2004; UNAIDS, 2005; WHO, 
2005a). This has two-fold benefits that could contribute to halting the further spread of the 
epidemic: It enhances prevention efforts among people, whether they have tested negative or 
positive, and it decreases the potency of the virus in individuals who are HIV positive and 
undergoing treatment, hence, rendering them less infectious (Abdool Karim et ai., 2003; Farmer 
et aI., 2001; Nattrass, 2003)4. Moreover, transforming AIDS from a terminal illness into a 
chronic disease can provide the impetus for overcoming community stigma and discrimination of 
PLWHA -- further strengthening prevention campaigns (Abdool Karim et ai., 2003; Lange et ai., 
2004; Stein, 2005). 
Until recently, the national implementation of a public sector ART programme in South 
Africa seemed financially impossible (Kovsted, 2005; Nattrass, 2004; Orrell et ai, 2003; Robins, 
2004). While the cost per patient used to be as high as US$ 10,000 per year for patented drugs 
(Kasper et ai., 2003), as a result of global activism and generic competition, alternatives are now 
available for US$ 156 per person per year (WHO, 2005b). Today, the debate is not so much 
should universal ART be provided by government (Nattrass & Geffen, 2004) but, rather, is it 
possible to implement in severely resource-constrained environments and, if so, what are the best 
ways to deliver these services (WHO, 2005a; WHO, 2006). The Western Cape public sector 
ART programme serves as an innovative case study from which to examine this question. In this 
province, the provincial government launched South Africa's first government-run programme to 
prevent mother-to-child transmission (PMTCT) of HIV in 1999, and expanded this in 2001 to 
include ART, making the project the first to use Antiretrovirals (ARVs) in government health 
4 In the context of HIV epidemics in developed nations, there is a school of thought that ART will lead 
PL WHA to engage in more risky behaviours as HIV / AIDS will be seen more as a chronic disease. Given 
this, and the fact that infected individuals live longer on treatment, there are scholars who question 
whether the reduced viral load as a result of treatment outweighs these other factors (Kovsted, 2005). 
Nattrass (2003) concluded that the evidential base of behaviour studies among men who have sex with 
men in Canada, Netherlands, Spain, Switzerland and the United States was a context not necessarily 
transferable to the primarily heterosexual driven epidemic in South Africa (and other African countries). 
She and other scholars have also found problems of selection bias and shortage of data in these cited 















facilities outside the context of clinical trials (Abdullah5, 2005b). Moreover, in 2004, the pilot 
ART project was scaled-up throughout the province (ibid). It is considered to be a highly 
effective and successful programme (Abdullah, 2005b; Bekker et al., 2006; Coetzee et ai, 2004a; 
Kasper et ai, 2003; MSF & UCT, 2003; Orrell et ai, 2003, TAC & ALP, 2004 & 2005; WHO, 
2003) as defined by its capacity to quickly and effectively treat a substantial number of people 
living with HIV/AIDS while yielding measurable reductions in AIDS-related morbidity and 
mortality (WHO, 2003). By December 2005, it was estimated that 55.7% of people that need 
ART in the Western Cape had access to it (Nattrass, 2006a) -- compared to a national average of 
10% for South Africa as a whole (Abdullah, 2006 quoted by Herman, 2006). 
Overview of Dissertation 
At the forefront of innovative ART programming, the Western Cape Province provides 
an important example for the rest of the country on how to successfully scale up HIV/AIDS 
treatment programmes. It also serves as a pioneering illustration to the global community that 
the use of ARVs at primary care level in resource-constrained settings is feasible, affordable6 and 
replicable. Furthermore, it offers insights into persisting bottlenecks and barriers confronting the 
rapid roll-out of HIV treatment, the achievement of national targets, and, most importantly, the 
goal of ensuring long-term universal and, thus, equitable access. As such, drawing from existing 
literature as well as interviews with key stakeholders, this study examines the factors that have 
ensured the successful provision and expansion of the ART programme in the Western Cape, as 
well as the persisting challenges of expanding coverage beyond current levels and building 
sustainable human resources and health systems to support it. 
5 Dr. Fareed Abdullah is the former Deputy Director General and Head of the AIDS programme in the 
Western Cape Province. He recently departed from this position in January 2006 (Herman, 2006). 
6 The Health Economics Unit at UCT has done costing studies that demonstrate that per life-year gained, 
the costs of ART are marginally less than the costs of providing appropriate health care in the absence of 
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Structure of Dissertation 
The first chapter provides an overview of the global HIV / AIDS pandemic including 
specifics for the Sub-Saharan Africa region. It considers the importance of access to HIV / AIDS 
treatment as fundamental to both public health goals and human rights principles. Following, the 
current state of access to ARVs globally is reviewed. Finally, it elaborates on South Africa's 
epidemic including the history and politics of national treatment advocacy and provision. A 
synopsis of South Africa's National Antiretroviral Treatment Guidelines is also provided. 
The second chapter describes the research methodology utilized. It details the research 
methods used and which informants were selected for this project and why. It also notes any 
potential constraints and biases in this particular study. 
The third chapter presents key findings of the critical factors that have contributed to the 
Western Cape ART programme's success. These include the epidemiology of the epidemic and 
historically strong health systems in the province, the lesson-building from the PMTCT 
intervention and pilot ART sites, the successful partnerships that have been cultivated, the 
strategies that have been utilized to ensure high rates of adherence and the leadership and 
management model of the programme. 
The fourth chapter presents key findings of the main challenges confronting the Western 
Cape ART programme. These include fostering equitable and universal access to AR V sand 
ensuring health systems strengthening in scaling up the programme. In considering equity, this 
chapter reflects on the programme's strategies in selecting ART sites and patients,whether both 
men and women are being appropriately targeted and reached and the programme's nutrition 
component. 












Other Critical Considerations Outside the Scope of This Study 
There are a plethora of other critical issues in ART scale-up that this case study will not 
elaborate on due to constraints in the length and scope of this paper. Firstly, it will consider ARV 
treatment for adults but will not explicitly detail the progress and challenges in reaching children 
who are HIV positive. This is a critically important area of study and the omission of this 
specific topic in no way minimizes its importance. 
Secondly, beyond the policy considerations already stipulated in contemplating equity in 
access to ART, there are a number of other socio-cultural factors that could also affect this and 
that merit further study. These include an exploration as to how the language of providers as 
compared to patients affects access and, ultimately, treatment outcomes; how the current 
disability grant requirements may impede potential patients from accessing ART services; and 
the role of traditional medicine7 vis-a-vis enrolment in the ART programme. 
Thirdly, while the success of HIV/AIDS treatment programmes is largely dependent on 
the effectiveness of HIV/AIDS prevention strategies, due to constraints in space, this study will 
not elaborate on how the prevention efforts in the province may have facilitated the HIV I AIDS 
treatment response. 
Lastly, treatment protocols, national and global negotiations with pharmaceuticals 
pertaining to prices of HIV/AIDS drugs, as well as South Africa's patent legislation vis-a-vis the 
World Trade Organisation's agreement on Trade Related Aspects of Intellectual Property Rights 
(TRIPS) (1994) deserves dedicated discussion. This is particularly warranted due to the fact that 
the South African government is still challenged to access cheaper alternatives of certain 
essential HIV/AIDS medicines through voluntary and compulsory licensing (Geffen, 2001; MSF, 
2005). While the researcher is unable to address this complex topic within the span of this 
dissertation, this critical area in ARV provision ultimately determines the affordability and, thus, 
the feasibility and sustainability of national roll-out ART campaigns. 
7 Traditional medicine is "diverse health practices, approaches, knowledge and beliefs incorporating 
plant, animal and/or mineral based medicines, spiritual therapies, manual techniques and exercises 
applied singularly or in combination to maintain well-being, as well as to treat, diagnose or prevent 
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CHAPTER 1: 
HIV/AIDS, Access to Treatment and South Africa 
The Global Context: The HIV/AIDS Pandemic 
Since its initial discovery in the early 1980s, HIV and AIDS has continued to rise in 
nearly all regions every year8, resulting in an estimated total of 25 million deaths across the 
world (UNAIDS, 2005). 2005 witnessed the highest number of people living with the virus, 
an estimated 38.6 million [33.4 million-46.0 million], with over four million people newly 
infected in the last year (UNAIDS, 2006). Moreover, in 2005 an estimated 2.8 million [2.4 
million-3.3 million] people lost their lives to AIDS (ibid). The vast majority (87%) of 
infections are acquired through heterosexual sex (Abdool Karim, 2005:243), with other 
modes of transmission including homosexual sex, childbirth, breastfeeding, blood 
transfusions, injecting drug use (IDU) and exposure to open wounds (Usdin, 2003). While 
the overall global HIV incidence rate (annual number of new HIV infections as a proportion 
of previously uninfected persons) peaked in the late 1990s, the number of people living with 
HIVI AIDS has continued to rise as a result of population growth and, most recently, the 
introduction oflife-saving ARVs (UNAIDS, 2006). 
Significantly, the percentage of women infected and affected by HIV/AIDS continues 
to increase disproportionately (UNAIDS, 2005). Women are not only affected by higher 
infection rates but also carry the burden of care and support for those with AIDS-related 
illness (Peacock & Botha, 2004). Sub-Saharan Africa remains the worst affected region and 
is home to almost two-thirds of all people and 77% of all women living with HIV (UNAIDS, 
2005) (see Figure 1 on the next page). Moreover, young women between the ages of 15 and 
24 years living in Sub-Saharan Africa are three times as likely to be HIV positive compared 
to young men of a similar age (UNAIDS, 2006). Furthermore, in six countries in Southern 
Africa (Botswana, Lesotho, Namibia, South Africa, Swaziland and Zimbabwe), the 
prevalence of HIV in pregnant women presenting at antenatal clinics is an astounding 20% or 
higher (UNAIDS, 2005). In addition, nine in ten children living with HIV live in the region 
as do 12.0 million [10.6 million-13.6 million] orphans9 (UNAIDS, 2006). 
8 A single exception is in the Caribbean region where the number of people living with HIV did not 
increase in 2005 (UNAIDS, 2005). 
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been utilized for addre's ing. for example. ,mali pox (Mann e/ al .. 1999). Specitlcally. these 
approaches ULIlt at allaining public health goals ""hilc simultaneously promoting and 
protecting rights. This ine~tricable link: between Health ~nd Human Rights originates f[(lm 
the recognition that atTaining lIeulth and Righh are complementary to achieving human ",dl-
being_ Th i ~ wa~ firsl arliculated LIl Article 25 or-lhe Universal DcclaratiolL or- Human Righls 
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Economic, Social and Cultural Rights (lCESCR) (1966). Specifically, Article 12(c) of the 
ICESCR empowers governments to take the necessary steps for prevention, treatment and 
control of epidemic, endemic, occupational and other diseases (Gruskin & Tarantola, 2002). 
Building upon these internationally-recognized legal frameworks, Mann et al. (1999:17) 
noted that: 
"The evolving HIVIAIDS pandemic has shown a consistent pattern through which 
discrimination, marginalization, stigmatization, and, more generally, a lack of 
respect for the human rights and dignity of individuals and groups heighten their 
vulnerability to becoming exposed to HITI". 
Therefore, in order to reduce the vulnerability of individuals and groups to the virus and, 
thus, effectively halt the spread of HI V, human rights frameworks should form the foundation 
of all HIV/AIDS public health interventions (ibid). Moreover, a human rights-based 
approach to addressing the enormous impact of HIV/AIDS on public health is the only 
realistic option for an epidemic concentrated in poor and marginalised communities, most of 
which don't have adequate access to health care or the ability to pay for treatment 
(Mukherjee, 2004). 
Building upon the UDHR -- which was ratified by over 140 countries -- the debate on 
access to treatment for HIV/AIDS has been fuelled against both governments and 
pharmaceutical companies in the name of human rights (Geffen, 2001). This has included a 
global grassroots demand for states to meet their obligations to respect, promote, protect and, 
most importantly, fulfil the rights to life, dignity, equality, information, education, 
participation, bodily integrity, scientific progress, non-discrimination, and, more specifically, 
the right to health, including health care. The right of everyone to the "enjoyment of the 
highest attainable standard of physical and mental health" (lCESCR, 1966: Article 12, 
General Comment 14) has four criteria: 
1 ) Availability (of sufficient services); 
2) Accessibility (physically, economically, culturally and in terms of information); 
3) Acceptability (within medical ethics and culturally-appropriate); and 
4) Quality (goods and services must be scientifically sound). 
Hence, national HIV/AIDS treatment plans must seek to meet these standards to fulfil state 
















that public health measures addressing HIV I AIDS that fail to consider other valid and less 
restrictive alternatives -- such as the provision of lifesaving HIV/AIDS drugs -- can be 
considered not only abusive to human rights principles but also to public health best practice. 
Thus, instead of the traditional dichotomous positioning of public health interventions versus 
human rights approaches, ensuring access to ART enables governments to meet both their 
public health goals in halting the spread and impact of the HIV/AIDS epidemic, as well as 
their human rights duties to citizens. 
Access to Antiretroviral Therapy: A Global Overview 
With the promise of transformation of HI VIA IDS from a terminal to a chronic illness, 
access to ART has been high on the global agenda. (See Appendix A for details on the 
workings of the HIV retrovirus and ART). This was evidenced at the historic United Nations 
General Assembly Special Session (UNGASS) on HIV/AIDS in 2001. Here, the Declaration 
of Commitment on HIV I AIDS was adopted by leaders from 189 Member States committing 
them to targets for the delivery of HIV prevention, treatment, care and support programmes 
needed to halt and begin to reverse the global epidemic by 2015 (UNAIDS, 2006). 
Moreover, access to affordable, quality and life-saving HIV/AIDS drugs is considered one of 
the most pertinent challenges in addressing the spread and impact of HIV/AIDS, and in 
fulfilling the UNGASS goals as well as the Sixth Millennium Development GoallO. Two key 
viewpoints are fuelling the momentum to rapidly scale-up public sector ART campaigns: The 
promotion and fulfilment of international, regional and national human rights obligations as 
well as the beneficial effects that access to treatment has on HIVI AIDS patients, overall 
prevention campaigns and, ultimately, the spread of the epidemic. While ART is widely 
available in developed countries, access to HIV I AIDS treatment is inadequate in low and 
middle income countries. 
In this context, in 2001, the UN Secretary General and world leaders called for the 
creation of a global fund to fight AIDS. In 2002, the Global Fund to Fight AIDS, 
Tuberculosis and Malaria (GF ATM) was launched as a private-public partnership aimed 
primarily at financing life-saving treatment efforts for the three diseases. Other bilateral and 
10 Adopted in 2000 by UN Member States the Millennium Development Goals are a set of global 
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multilateral support for treatment has also increased in response to WHO's "3 by 5" 
campaign launched in 2003 aiming to provide ART to 3 million PL WHA in low and middle 
income countries by the end of 2005. While this campaign far from reached its target, access 
to ARVs in resource-poor contexts has greatly increased largely due to the GFATM, the 
World Bank's Multi-Country HIV/AIDS Programs (MAP) and the U.S. President's 
Emergency Plan For AIDS Relief (PEPF AR) (UNAIDS, 2006). However, despite the 
availability of financial resources, and drastically reduced generic prices, many countries are 
struggling to roll-out treatment campaigns in the face of numerous infrastructure and systems 
barriers as well as socio-economic inequalities (WHO, 2005a). Most countries in Africa 
report that the demand for treatment is surpassing their capacity to supply it (ibid). Currently, 
20% of the people who need HIV I AIDS medicines in low and middle income countries have 
access to them (WHO, 2006). 
This situation has sparked a renewed advocacy campaign to ensure access to 
HIV/AIDS treatment in poor countries. In 2005, commitments towards achieving 
universal access to treatment for all those who need it by 2010 were re-affirmed at the 
Gleneagles summit of the G8 industrialized nations and at the World Summit meeting 
held in September 2005 at the United Nations Headquarters (UNAIDS, 2006). This 
spirit was further echoed within the Africa region at the recent Special Summit for the 
African Union (AU) on HIV/AIDS, Tuberculosis and Malaria in May 2006 (AU, 2006). 
Amidst these global and regional advocacy efforts, there have been pockets of success 
in scale-up in the last two years. By the end of2005, the number of people accessing ART in 
developing countries increased from 400,000 in 2003 to 1.3 million (UNAIDS, 2006). Figure 
3 on the next page shows the regional distribution of this ART coverage, including the 
estimated number of people receiving and needing ART between December 2003 and 2005. 
Notably, in the Sub-Saharan Africa region, scale-up to ART has been dramatic with an 
estimated 810,000 people on treatment in 2005 as compared to 100,000 in 2003. Figure 4 
diagrammatically represents this rapid rise in coverage in the region. This sharp increase is 
attributable to a handful of countries, namely, Botswana, Kenya, South Africa, Uganda and 
Zambia (ibid). While WHO and UNAIDS recently estimated that only one out of six people 
of the 4.7 million people who need ART in Sub-Saharan Africa now receive it, significantly, 
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HtV/AIDS and Treatment in South Africa 
South Africa's III V/AIIlS F:pidemir 
Oll~ (lfthc wor,\ i!tre~kd ~(luntn es ill the world. South Afi-i~a', IlIV/A IDS epidemic 
is still 011 the in<.:rcase (IJKAIDS, lODl». In 2005. ao ~sti!T\a",d 5.5 mllholl [4,Q millioll---O. I 
mil llon] South African, \\'~r~ living with HIV and there was an estimakd ildLilt (15-49 yc~rs) 
pre'aicnec rate of 18.8% [ I o_8~o-20, 7%] {DOH, 2()()6a; UNAIDS. 2006)", M(lT~(lV~r. in the 
l ~,t 15 ~cars. prcv~lellcc r~t es of pregnant women prc,~nting ilt antelliltal dillies hJ\c riscn 
dramatlcally Ii-om a low 0.7"/c, in 19<)0 to 30.2% 1l1 20D'i -- wi th some ~rCii S ,howing more 
than one nul nfthrce prqmant wOmen testing posi ti ve for HIV (DOH, 200l>a) (See Figllre 5). 
Prevalence is highest amon~ women aged 25 H years (ibid) (Sc~ Figure fi On th~ nex1 raSe). 
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In the ,ountry's wor;sl-arrec\"d province. KwaZuli.l-"latal , antenaTal prevalence has rea,hcd 
OVCI' 3'P'o. while it has remained cxccptiollally high at hd"een ~9% and 35% in th~ Pastern 
Capt. Frtc Slale, Gauteng. J\1pumaJanga and North West pro\'Hlces (ibid). (Ste FiglJ~e 7 
below j(,r a map ,,[South Africu ootil1g the difthenJ provinces). 
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South Africa also remains the country with the highest number of people infected with 
HIV, and HIV/AIDS has become the primary cause of death in the nation for both males and 
females (MRC, 2003). Furthermore, the recently released 2003-2004 mortality report points 
to some alarming changes in mortality statistics that are attributable to the epidemic. For one, 
deaths among women have increased 93% between 1997 and 2003 compared to a 60% 
increase among males in the same period (Statistics South Africa, 2006). In addition, in 
2003, for the first time ever, people aged 30-34 years were dying in larger numbers than 
people in their 60s (ibid). 
National Context: Treatment Advocacy and Provision 
Despite South Africa's ratification of key international and regional agreements that 
render the government accountable in upholding its human rights obligations, as well as a 
Constitution that creates an enabling human rights environment for policy formulation and 
implementation (Government of the Republic of South Africa, 1996; UNHCHR, 2004), 
access to ART in South Africa has been marred with political controversy and side-stepping. 
Government's reluctance to develop an HIV/AIDS treatment policy instigated a demand for 
access to ART that ripened into a social movement, primarily led in the public domain by the 
Treatment Action Campaign (TAC), a Non-Governmental Organisation (NGO) formed in 
1998 with headquarters in Cape Townl2 . Drawing upon international and regional human 
rights instruments as well as the South African Bill of Rights, T AC has used explicit human 
rights and legal arguments to pressure the Government of South Africa to provide HIV I AIDS 
treatment (TAC, 2003, 2004 & 2005a). 
In early 2001, in a move to quell activist voices, the South African government 
announced that selected hospitals would offer PMTCT (Van der Vliet, 2004). However, by 
July 2001 this decision had still not been implemented and some government officials were 
arguing that initiating PMTCT was not an effective, sustainable and affordable government 
policy (ibid). In April 2002, in an ensuing legal battle between T AC and the Department of 
12 There have been many other key actors in this advocacy effort including academics, health care 
providers, civil society organisations as well as some Government representatives at different levels. I 
am highlighting the Treatment Action Campaign in particular because their efforts have included 
mass grassroots mobilization and activism that has been well documented both nationally and 
internationally (Butler, 2005; Friedman & Mottiar, 2005; Heywood, 2004; Leclerc-Madlala, 2005; 
Robins, 2004). Moreover, as an organisation, they have propelled the South African Government as 













Health (DOH), the Constitutional Court ordered government to provide drugs for the PMTCT 
of HIV at all public health-care facilities in South Africa (Abdool Karim, 2004). The 
following year, in October 2003, the government finally heeded the calls by activists for 
provision of free ART at the national level and announced an Operational Plan for 
Comprehensive HIV and AIDS Care, Management and Treatment (DOH, 2003). This 
represented the final part of South Africa's mutli-sectoral National Strategic Plan for HIV 
and AIDS (2000-2005) (Marshall, 2004). 
This Operational Plan alms to ensure universal, equitable and sustainable 
implementation by all levels of government; quality of care including the safe use of 
medicines; strengthening of the National Health System; reinforcing of the government's 
prevention and nutrition strategies; provision of an accountable continuum of care and 
treatment; promotion of individual choice of treatments as well as healthy lifestyles; and an 
integrated response to HIV and Tuberculosis (TB), including Multi-Drug Resistant 
Tuberculosis (MDR-TB) (DOH, 2003). The programme plans to distribute ART through 
service points in every local municipality within five years, aiming to treat 1.2 million 
peoplel3 by 2008 (Marshall, 2004). In no other country has an HIV/AIDS treatment plan 
attempted to reach such large numbers of people (Ncayiyana, 2004). Moreover, in order to 
assess a service point's capacity to successfully implement ART, the Operational Plan 
outlines 23 requirements that each site must meet in order to be accredited to provide ARVs. 
These include, for example, a service point manager; a trained team on site which includes 
clinicians, nurses, counselors, dieticians, social workers, pharmacists; and links with NOOs in 
the service area (DOH, 2003 :98-1 00). While a national team is accountable for the 
accreditation process, the Provincial Departments of Health are responsible for projecting 
provincial needs for ART as well as locations of service points -- while ensuring equitable 
access to this service (ibid). 
13 It is important to note that simply initiating people on treatment and, hence, reaching target numbers 
does not necessitate reduction in viral replication and positive health outcomes in patients ifthey 
don't adhere to medications. The 'numbers drive' to ensure large numbers of people on therapy must 
not be at the expense of long-term quality medical care and patient support to ensure adherence 
(Kovsted, 2005). Moreover, Prof. Wood of the Desmond Tutu HIV Centre notes that merely 
monitoring the head count of people on treatment as well as clinical analysis of those on ART does 
not adequately measure the impact of ART programmes on morbidity and mortality at the population 
level (Wood, 2006, personal comm., 7 August). Recent research in South Africa -- on the brink of 
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Sin<:c 2004, provm~i~l rol1oul has Ile~n slow largely du~ to delays in ohtainmg 
accreditation lor treatment site~, ~hortages In supplies of ARVs, lX)()T infonnation 
dissemination campaigns ~l1d a bck of de..r national direct ion in lcchni~ul am! 
mdhndologica] issues that arist in implementing the plan (Abdou! Karim & AbdooJ Karim, 
2005; Abdullah. 2005a & 2005b: TAe & ALP, 2004 & 2005). \Vhilc Nariollal Amirelro" iral 
li-ell/men! Guidelines have been lkveloped (DOll. 2004), other im)X'11mlt n"t ionai polky 
directives arc ,till needed to ensure (he effective and equitable implementation of the 
Operational Plan aCross all provinces. This includes. but is not limited to, appropriate 
guidance on testing. nutrit ion, prevention and training und support of health-care persollnel 
(Abdoo] Karim. 2(04). Furthermore. while a country pbn for Human Kesouret~ for Ht~Jth 
(l [RII) wa~ rteem!y rek~std in Apri [ by the n"liona[ 001 L thne has bten litt It con~ultalion 
with ,tJkeholder~ regarding its implementation vis-il-vis ~<:ahng op ART (lTPC. 2()()(,). 
Whilt Sooth /\fri<:a is taring better than other <:ountries in tht region in thi~ regard (~ee 
Figllre 8 below). hUlTlan resource ,hortages in relation to workload j(,r HIV/AJDS treatment 
and Care p~rsist as one or the key challenges in implementation 0 r the Operational PI an 14 _ 
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"Jevcrthdcss, within the framework of the c.;:isring national AI{ V guidelines. each 
pmvincc has been allocated funds by national government for implementatioll and has 
del'eloped its own system or dchvcty. Some provinces ha\'~ sClcccsslully lilrgcd ahead with 
implementation. weh a, 11\ the Wcskm Cap..:: mal Gaulcng, ,,·hile olhers hke the Fr~", Stak. 
Limpopo and 'v1purnalanga hale had a stalll'l star! (DOH, 2006b; l\altrass. 2006a; \ldJov " & 
Daswa, 2()(}6a: TAC & ALP, 2(05). Figllre \I below oRllict, prminciai ART r0l1-()",I~ as 
<x>mparcd to the Operational Plan large!s. This clearly ,]\0WS that, unlike other prnvlIlcc,. Ihe 




















Fig..-. 9 : PRO'",-,CI'L ART ROLLOI-'1 ~s ~ P'RCf,'~ \GO 011 >l. O .. RA [ION \L 1'1 ," T ""GH. (;'1; ,\ T"IR,W,_ lIH~, \), 
Furth~nnor~. across th~ countr),. by th~ end of D~cemhcr 2005. 204 facilities wcrc providing 
ART ;;cn'iccs, with all 53 hcalth d;;;!riCIS having at ka~t onc hcalth jac;lity providing ARI 
and 63% ofthc 252 sub-districts ha\ ing full covCTagc (DOH, 2()(Mb). Figure I() on th~ n~xt 
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Frel! Stale 5 5 
Giluteng 6 29 
KwaZulu-Natal 11 54 
Limpopo 6 23 
Mpumalanga 3 12 
Northern Cape 5 11 
North West 4 8 
Western C<lpe 6 42 ---------
TOTAL: 53 204 
Fi~"r< 10 : t', \]81R 01 flUlTII DIY' RiCT> ."" 0 1" ,,-,no'" .. RT fI' .AI III r AC 11 .1 III' '" 1'., "',,, i', E,,, 
J)", • "H '_ "- lOOS. ([It eAR I '" " 01' II ,·" III, 21~)(,"). 
Despite the great discrepancies between provinces in ART roll-llllt a~ noted uho,~, 
South Africa has succeeded in s~alil1g-ur tr~atment llllmh<->n; nationally_ Of lr.., 
appro;<;imatdy 800.000 p~orle living Wilh HIVlAIDS m Soulh Alnca and requiring treatment 
(Nattra". 2006a). a~ ofJun~ ~OO6. approximately I.tO_OOO patients "ere On ARVs through 
the public ~ysl~m in aU mn~ provmc~s (JCS~fF_ 2006h) as compared In a mere 2.000 people 
in (kloher 200.1 (l\'altru%. 2()(}6a)I~_ Moreo\er, an addilional 9'OJ)()() people arc estimated to 
he receiving treatment through private ,edor ~ource, (JCSMF. 2()()6a). Non~theless. this 
mean'> that kwcr than 30",'0 p~re~nt of South Africans who need ART arc accessing it (see 
FiXure If on the next page), A recent ecollOmetrie analysis of the dctemlinJI11~ atl'ccting 
ART coverage indicated that South Africa's implementation has been relat ively pl)()r given 
its economic, institutional and ~pidemioJogical attributes (Nattra~s. 2006b). Amid~t the up-
hill challenge of achi~vi ng universal access to treatment. persi~ti ng conn icting m~~,ug~~ from 
th ~ '\iini,tcr of lkalth ahout th~ cfjieucy aml cfteeti,cnes~ of ART vi,>-a-vi'> nutritional 
suppl~m~nl> ha\'~ aJ~o plagued communiti~, wllh mnfu,]()n as to how and "hethcr to '>eek 
tre3lm~nt (Nattra%, 2fKl!ic: Ndlo\'u & Daswa. 2006a: Opie, 21l(5), 
., Pica"" note that due to the per,i,ti ng lock of a national monitori ng and eyal uat ion 'y'tem for AKJ 
pro\ij,ion, the nattorwl Ikpartoncnt of Health has not~J that thc t"" al lIuon ber or paliClIt> rc<:ci\'ing 
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National Antiretroviral Treatment Guidelines 
It is important to understand the policy directions offered by the National 
Antiretroviral Treatment Guidelines for this case study. While WHO (2004a) recommends 
triple combination first-line ARV therapies for the long-term treatment of adults and 
adolescents, there is still much debate over when exactly to initiate treatment (Kovsted, 2005; 
Wood, 2005). The South African National Antiretroviral Treatment Guidelines have dictated 
the following clinical criteria for adults to be eligible for ART through the public sector 
system: The patient must either have a CD4+ cell count of less than 200 cells/mm3 
irrespective of the WHO stage of illness, or must be in WHO stage IV of HIV disease 
irrespective of the CD4+ count (DOH, 2004:2)16. Furthermore, there are special 
considerations for women of childbearing age or who are pregnant, children, people with 
HIV and TB co-infection and IDUs (DOH, 2004). 
In addition to clinical eligibility, the treatment guidelines also specify psychosocial 
criteria for consideration when selecting a patient for ART (DOH, 2004:3): 
• "Demonstrated reliability, i.e. patient has attended three or more scheduled visits to an 
HIV clinic; 
• No active alcohol or other substance abuse; 
• No untreated active depression; 
• Disclosure: it is strongly recommended that patients have disclosed their HIV status to at 
least one friend or family member OR have joined a support group. 
• Insight: patients need to have accepted their HIV-positive status. They need to have 
insight into the consequences of HIV infection and the role of ART before commencing 
therapy. 
• Patients should be able to attend the antiretroviral centre on a regular basis or have 
access to services that are able to maintain the treatment chain. Transport may need to be 
arranged for patients in rural areas or for those far away from the treatment site." 
16 Prof. Wood of the Desmond Tutu HIV Centre observes that there are many persisting challenges 
regarding medical eligibility for ART in South Africa. For one, most people do not know their HIV 
status let alone CD4+ count to qualify for treatment. With the exception of mothers captured through 
the PMTCT programme in antenatal clinics, most PL WHA are referred to ART sites when they are 
already very sick with AIDS. Some believe that there is a need to re-think the HIV / AIDS programme 
to incorporate VCT Plus sites that allow for counselling and testing as well as CD4+ counts --
enabling eligible patients to be identified and begin treatment earlier on (Wood, 2006, personal 





















These criteria aim to ensure that patients are ready to adhere to this life-long daily treatment. 
They are not intended to be exclusionary and the final decision is supposed to be taken by a 
multi-disciplinary team at the ART centre in conjunction with the patient or caregiver. 
Figure 12 below shows the HIV management flowchart that health practitioners use to guide 
them in making HIV / AIDS treatment decisions with the patient. 
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In the context of a burgeoning HIV / AIDS epidemic, the recent national government's 
HIV/AIDS treatment plan, combined with an injection of both national and international 
financial resources and falling prices of HIV/AID drugs, has paved the way for national 
scale-up of ART in South Africa. The Western Cape Province serves as an important 
example to other provinces as well as the global community that ART programmes 
implemented at the primary care level in resource-poor contexts can be feasible, effective 
and, importantly, replicable. This research study explores the success factors and persisting 
challenges in the public sector ART roll-out in the Western Cape, and takes the form of a 
case study. Specifically, it examines key aspects contributing to the programme's 
documented success in reaching large numbers of people who need ART and in ensuring 
positive health outcomes and survival rates. In addition, it considers continuing challenges 
confronting the programme in reaching the target of universal access to ART as well as in 
ensuring health systems strengthening at the primary care level. The level of analysis in this 
study is at the provincial policy/programmatic level (meso), examining provincial strategies 
that are determining the health outcomes for people who need ART in the Western Cape. 
Using such a case study approach permits an in-depth examination of the specific 
context of the Western Cape Province, allowing for valuable insights and lessons to be 
illuminated. While it is not possible to adequately extrapolate conclusions from a single case 
study, it is hoped that this work will generate some research questions and policy directions 
that can be further pursued within the Western Cape as well as in other provinces. Moreover, 
with the roll-out of ART being a recent global endeavour, there is still a dearth ofliterature 
on how developing countries are successfully implementing ART programmes as well as how 
they are finding entry points to address challenges in this area. The researcher hopes that this 
work can also generate ideas for other low and middle income countries that are experiencing 














The following research methods were used in this study: 
• Literature review; 
• Qualitative research design; 
• Interviewing and analysis; and 
• Thematic analysis. 
In formulating valid arguments for this dissertation, a process of triangulation was used. This 
involved cross-checking findings from the interviews with published literature -- where it 
exists -- to ensure the validity of claims. 
Interview Process and Case Data Collection 
Formal interviews were conducted in the period of June to August 2006 with 16 
individuals and these form the primary research for this dissertation. Given that this study's 
level of analysis is at the meso level, informants were sought at the management level of the 
ART programme. More specifically, key stakeholders were targeted including the Provincial 
and City of Cape Town Departments of Health, important implementing NGOs working with 
the provincial government in delivery of the public-sector ART programme, key 
academics/clinicians who have been instrumental in the roll-out process in the province, as 
well as treatment advocacy 'government watch-dog' organisations. The general assumption 
guiding this strategy is that programme managers have an informed understanding of policy 
implementation and of patient-oriented challenges. 
Qualitative interviews were conducted and were semi-structured in nature asking key 
questions to all interviewees about the success factors and challenges in the Western Cape 
ART roll-out. Additional questions were also formulated for each particular informant based 
on their area of expertise. Interviewees were encouraged to talk freely around these questions 
and contribute other information that they felt was important to this study. The findings from 
these interviews, combined with the research from the literature, form the basis of Chapters 
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Informants 
Provincial Department of Health 
Dr. Keith Cloete: Provincial Director for HIV/AIDS, Sexually Transmitted Infections (STIs) 
and Tuberculosis (TB) and Acting Chief Director for District Health Services and 
Programmes. In this role, Dr. Cloete is responsible for the ART programme in the Province. 
A public health expert, Dr. Cloete has held numerous senior public health positions and has 
been working in the Western Cape for many years. 
Dr. Nevilene Slingers: Provincial ARV Programme Manager. Dr. Slingers is responsible for 
overseeing implementation of the ARV programme and for human resource management for 
treatment provision. In this role, she manages all the dedicated ARV clinics in the Province. 
Dr. Slingers has been working for the public health sector for many years and has held 
various positions, particularly within primary health care service delivery. 
Ms. Meg Osler: Co-ordinator of the ARV Monitoring and Evaluation Programme of the 
Provincial Department of Health. Ms. Osler is responsible for improving systems in all 
Western Cape ART sites to enable effective outcome-based monitoring and evaluation of the 
ART programme. 
Ms. Luzette Van Nierkerk: Assistant Director of the Integrated Nutrition Programme, 
Comprehensive Health Programmes of the Provincial Department of Health. In this role, Ms. 
Van Nierkerk is responsible for the following key areas: Disease-specific nutrition support, 
treatment and counselling including for HIV/AIDS patients, micronutrient malnutrition control 
and food service management. This includes coordinating with the HIVI AIDS Directorate in 
provision of supplemental nutrition for ART patients that are food insecure. 
City of Cape Town Department of Health 
Dr. Ivan Toms: Director of Health of the City of Cape Town Department of Health. Dr. Toms 
is responsible for Primary Health Care and oversees all city health programmes including the 
HIV and TB programmes. He founded Empilisweni SACLA Clinic which is responsible for 
training community health workers. Dr. Toms also became a National Co-ordinator for Service 
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Dr. Pren Naidoo: Director of HIV/AIDS and TB of the City of Cape Town Department of 
Health. Dr. Naidoo is responsible for overseeing and coordinating ARV treatment provision 
and supporting services offered in the Cape Town metropolitan area. 
Implementing Partners 
Dr. Eric Goemaere: Head of Mission of Medecins Sans Frontieres (Doctors without Borders) in 
South Africa. Dr. Goemaere provided technical assistance to the Western Cape Department of 
Health in running their first PMTCT programme in 1999 in Khayelitsha. In 2001, he also set up the 
first pilot ART site in South Africa in the Western Cape Province within a government-run primary 
health care setting -- also in Khayelitsha. He has vast experience as an HIV practitioner and a 
wealth of knowledge on successfully expanding provision of ART within an urban resource-poor 
context. In partnership with the Provincial Department of Health, he continues to oversee all 
existing three ART sites in Khayelitsha. 
Dr. Ashraf Grimwood: Executive Director of Absolute Return for Kids (ARK) in South 
Africa, an international (U.K.-based) NGO. A clinician himself, Dr. Grimwood has years of 
expertise as an HIV practitioner both within the private and public sector and has been a key 
stakeholder in supporting the roll-out of ART within the Western Cape Province. Before 
ARK, he served as Director of the South Africa HIV AC Medical Research Council since 
2002, and Director of the Bristol-Myers Squibb (BMS) HIV/AIDS Research Institute in 
South Africa preceding this. In August 2003, Dr. Grimwood was appointed by the South 
African President to the 16-member South African Aids Task Team responsible for the 
development of the detailed plan to roll out anti-retroviral treatment for the country. He is 
also a contributor to the National Antiretroviral Treatment Guidelines. 
Ms. Anita Jason: Patient Advocate Programme Manager of Absolute Return for Kids (ARK) 
in South Africa. Ms. Jason has expertise as a community liaison manager and in developing 
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Professor Robin Wood: Director of the Desmond Tutu HN Centre, Institute for Infectious 
Disease and Molecular Medicine, University of Cape Town and a Professor of Medicine. The 
Desmond Tutu HN Centre runs the community ARV clinics in Gugulethu and Masiphumelele. 
Since 1993, Prof. Wood supervised the first dedicated HN clinic in the Western Cape at 
Somerset Hospital and he has extensive experience in administering ARV s. He has published 
widely on HIV management, ARV adherence and TB interaction with HN. Prof. Wood also 
serves as TAC's medical advisor. 
Academics/Clinicians 
Dr. Gary Maartens: Clinical pharmacologist, founder of the adult HIV clinic at Groote 
Schuur Hospital and lecturer at the University of Cape Town. Dr. Maartens is the Head of the 
Division of Pharmacology and the former Head of the Infectious Diseases Unit at the hospital 
and is widely regarded as the country's leading HIV clinician. He also serves on national and 
local health policy committees. Dr. Maartens assisted in the formulation of the National 
Antiretroviral Treatment Guidelines and is an editorial board member of Lancet Infectious 
Diseases, the Southern African Journal of Epidemiology and Infection and the Southern 
African Journal of HIV Medicine. 
Dr. Andrew Boulle: Researcher at the Infectious Diseases and Epidemiology Unit, University 
of Cape Town. Dr. Boulle has been instrumentally involved in the MSF and Provincial 
Department of Health ART sites in Khayelitsha since their inception. He has also published 
widely on the provision of ART through the public sector and is the author of the CT ARV 
Costing Model that has been generically adapted and approved by WHO. In addition, Dr. 
Boulle has developed an HIV clinical information system model that is being used by the 
Provincial Department of Health in monitoring and evaluating ART implementation. 
Civil Society Partners and ARV Roll-Out Monitoring Organisations 
Ms. Sipho Mthathi: General Secretary of the Treatment Action Campaign (T AC). Ms. 
Mthathi was elected to this position at the Third TAC National Congress in 2005 having been 
a T AC member since 2000. She played an instrumental role in setting up T AC' s branches in 
the Western Cape and also led the design and implementation of TAC's Treatment Literacy 
Programme, which has been recognized by UNAIDS as a best practice. As General 













Ms. Fredalene Booysen: Provincial Organizer of the Western Cape Treatment Action 
Campaign (TAC) Provincial Office. Ms. Booysen liaises with all TAC Western Cape branch 
and district offices, organizing T AC activities and coordinating with key stakeholders to 
address challenges in ART implementation at the community level. 
Ms. Ntombozuko Khwaza: Treatment Project Co-ordinator of the Western Cape Treatment 
Action Campaign (TAC) Provincial Office. Ms. Khwaza coordinates TAC's own treatment 
provision within the province -- working to identify needs and gaps in coverage from the 
public sector ART programme. 
Ms. Fatima Hassan: Attorney and former Deputy Head of the AIDS Law Project (ALP) and 
secretariat of the Joint Civil Society Monitoring Forum (JCSMF). Ms. Hassan works in the 
Law and Treatment Access Unit of the ALP in Cape Town. She has extensive expertise in 
public interest litigation, education, training and legal reform in the area of HIV/AIDS and 
discrimination, and was appointed by the Minister of Health as a member of the Council for 
Medical Schemes. In her role at ALP, she monitors the implementation of the national 
Operational Plan. 
Potential Constraints and Biases of the Dissertation 
It is imperative to chronicle factors that may have biased this dissertation. While 
there were no significant constraints in accessing key stakeholders and relevant information, 
it is important to note that particular emphasis has been placed on ART sites which had the 
greatest accessibility and published literature. These include government ART sites being 
supported by MSF in Khayelitsha, ARK and the Desmond Tutu HIV Centre in Gugulethu and 
Masiphumelele. As such, this study could be considered biased in its geographical representation 
ofthe roll-out of the ART programme in the Western Cape. 
In addition, an interview with Dr. David Coetzee, Director of the Infectious Disease and 
Epidemiology Unit and lecturer at the University of Cape Town, was desired but, unfortunately, 
due to his heavy work load he was unable to avail himself for a meeting. 
Furthermore, since this research is being conducted at the meso level, it is potentially further 
constrained by the lack of perceptions and experiences at the patient level, and this would be an 
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It is important to also note how the researcher's own identities may have influenced this 
study. For one, the researcher is a foreigner (Lebanese-American). While this did not affect access 
to key stakeholders to interview, and there were no language barriers encountered precluding the 
successful completion of interviews, it could have influenced the lenses by which the data was 
analyzed. Conversely, being a foreigner may have provided this study with additional insights that 
would not have been obviously apparent otherwise. Bernard (1994) notes that the advantages of 
a researcher being an outsider is that he/she notices socio-cultural patterns that insiders often 
take for granted. In addition, the researcher is currently employed by the United Nations 
Development Programme's HIV/AIDS Group at its headquarters in New York and has many 
connections to the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF A TM). This 
could have resulted in the research having a subjectively biased view. Moreover, the 
interviewees were made aware of the background of the researcher and, as such, could have 
adjusted their statements in the interviews -- particularly when considering persisting 
challenges -- in an effort for the programme to appear more favourable. 
Finally, a possible and significant constraint in this work stems from the diverse range 
of levels of wealth between provinces in South Africa as a result of the legacy of apartheid --
with the Western Cape being one of the richest of the nine provinces (Cummins, 2002). 
Literature has shown that the level of wealth is a key determinant in the spread of the 
HIV/AIDS epidemic (Barnett & Whiteside, 2002). It has also been suggested that this 
determines the corresponding aggressiveness and efficacy of national HIV/AIDS responses. 
As a bare minimum, because government in richer countries/provinces/districts have greater 
access to financial and other resources, and tend to have 'stronger' governance structures and 
systems, responses to public health threats such as HIV / AIDS tend to be swifter and more 
expansive (Gauri & Lieberman, 2004). Moreover, cross-national statistical analyses have 
shown that GOP per capita is correlated with higher levels of per capita government spending 
on HIV/AIDS, even after controlling for variances in estimated levels of HIV prevalence 
(Lieberman, 2004 quoted by Gauri & Lieberman, 2004). Hence, since the relative wealth of 
the Western Cape Province cannot be controlled for with comparison to other provinces, this 
factor may in fact 'over-ride' another province's ability to benefit from some of the lessons 
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Scaling Up of Antiretroviral Therapy in the Western Cape: 
Key Factors that are Contributing to the Programme's Success 
Within the national milieu of government resistance to providing ARVs, in 1999 the 
Provincial Government of the Western Cape Department of Health (PGWC) forged ahead 
with implementation of PMTCT and a pilot ART project in 2001 -- long before the national 
Operational Plan was launched. Due to the subsequent adoption of this treatment plan (with 
accompanying human and financial resources for provinces), substantial donor funding in the 
Western Cape (particularly R430 million over five years from the GFATM (Thorn, 2004)17), 
and drastic reductions in ARV prices, the Western Cape was able to roll-out a treatment 
programme throughout the province in the course of 2004 and 2005 (Abdool Karim, 2004; 
Abdullah, 2005b)18. Many partners believe it was "well placed to do well" given the 
province'S demonstrated political will early on to provide this service through the public 
sector, as well as its prior experience in administering HIV/AIDS drugs19. By June 2006,44 
ART sites had been accredited and were providing therapies to adults and children with the 
aim to expand this to 50 sites by April 2007 (PGWC & UCT, 2006). Furthermore, as Figure 
13 overleaf illustrates, by the end of June 2006, more than 20,000 people were receiving 
ART treatment. (See Appendix B for a full list of the current operating sites in the Western 
Cape as well as patients on ART in June 2006). 
17 Two-thirds of this GFATM grant is allocated to the provision of treatment and this greatly jump-
started the province's ability to rapidly scale-up ART (Cloete, 2006, personal comm., 8 August; 
Naimak, 2006). 
18 Cloete, 2006, personal comm., 8 August. 
19 Boulle, 2006, personal comm., 27 July; Goemaere, 2006, personal comm., 18 July; Hassan, 2006, 
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FI~u" Ll : pu If X,"" -I.IU " "'" "'" '-R' C " ', M~'L lOO~ _Jl. " . 2006 (~I.l~GI_R" PRm ''''"I. Go\'F_R~"L" 
Onll[ WESHR~ C • • E, WOo). 
In the absence of a natiOllul monitoring ~nd c\"~lu~tion system (lTrc. 2Cl(6). the 
PGWc. in partnership with the l:ni~crsily of Cap" Town (\JCT), has efJi,~ti\'ely de\'eloped 
Its own -- resulting in the Weslcm Cape h'-~ng One nfthe only pro\'in~es in South AI'ri~a with 
adequale data \0 offer tangible oulwmcs from ART ddi\'cry'o, As nOled already In Figure 
10, the pro\'in~c has roll~d oul ART swiftly, cXl'ccding the Op~rational Plan targets for 
2004 and 2OOS. With 72% of the Westem Cape provincial population u,;ing the public ,;ector 
health system (Abdullah, 2005aj, this speedy ART programme expansion offers much hope 
to PL WI IA in thc provim'c. 13y December 2005. it w~s cstimated that 55,7% of people that 
need AR r in the Wcstcm Cape had access to it (Nal1mss. 2006a) -- comparcd to a national 
~\'cr~ge of 1 0% (Abdullah. 2006 quoted by I lerman, 20(6), 
FolloW)ll!l I will discuss the hy t:'~tors tl"'t ~re ~'ontributin!l to the success of thc 
ART sc,lk-up in the Western ('~rc. It is imrort~nt to not~ th~t ne~rly all intonl1~nts h~d 
consensus on lhcsc themcs as aspeds that h,ne facliitatcd lhe programme's eiTe<:tive 
perfonnancc. 
" I:loullc. 2006, pcrs0I1"] cOlnm .. 27 Juty; (irimwood, 2(HI6, persUlal comm., 10 July: Osler. 2()06. 
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Epidemiology of HIV and Historically Strong He<llJ:.h Systems in the 
Western Cape 
Literaturc has ~,tahlishcd that pcrsons who are cconomically disadnntaged ha\'c 
grcatcr susccptibility to IllV infcction (['enron. 2004: llcad. 1992: Kali<:hman el al,. 2005: 
\1cCoy, 2003: Stillwaggon. 2002 & 20(3), [he \\lcstern Capt" consisting of 10.1% of the 
South African population. has thc highcst lcvel of per capita income. cmploymcnt and 
literacy in South Africa a, c\'idcnced by thc Human Dcvelopmcnt Index (Abdullah. 20()5b: 
Statistics South Africa. 2003). Givcn thc higher socio-economic status of the Wcstcrn Capc 
population. the HIV prcvalcm'c is lowcr than allY other provincc and is almost half the 
national average (30,2%) at 15.7"-1> (DOll . 2006a) (sce Figure 14 below for a comparison of 
Jjl\,! prcvalcw;c ratcs by provinces among antcnatal clinic attcndces"'. 2003-20()5), 
Nc\crthdcss. thc cpidcmic has continuc<l to incrcasc ov.,.- thc last kn ycars from a pre\'alcncc 
ratc of 1,2% in 19()4 to 15,7% in 2005. and it is cxpccted to continuc in this upward t",nd 
o,er thc nc"t li\'c ycar<; (Ahllliliah. 2005b: DOH. 2006a: PGWC, 2()()5) , HIV/AIDS accounts 
ttlr thc largest burd~>J1 of discasc in thc provincc and IS thc largcst CaUSC of mortality among 
~hi ldren anll womcn agcd 15-29 (Ahdullah, 2005h:24R) As <;uch. plihlic health officials 
" 'CW lt as thc "<;inglc largcst health crisis facing the W c<;tem Cape at thc prc<;cnt time" (ihidJ 
Fi~u" t4 : PRO\'l'C'.<l 111\ P RLVAlL.""E ~<r"' .... L." A,-, L'l.HAl ('U'I, A nL~')) • '. ~""lH A,KIC ,'- lIHI.l_lIHI5. 
(Dl .A", ".," Ot II •. " "'. lU06,\) 
" Acooemics quc;tion Ht V pTC,,"lcn,'C ratC, that aft' cxtrapolakd from antcnatal clinic 'lir"",!" that 
on l} t~rgel ""mcn who h~vc unpmte<:ic<i '<t:~. 'mCC thcy arc pregnanl. '" well "' women of low '<xio-
"",onomic status who arc u,in& publ ic hcalth ,cr\'k-e< as tht'j' c~ n'l alfo],d pri\'ate hcalTll c~]'c. Th~1 is. 
ibc d"i" docs nol adeYlLaicly represent "II populations group> in SWlh Africa (lloumc, 2005), 
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While the Western Cape remains one of the richest of the nine provinces with, for 
example, the highest public spending on health, there are extreme disparities between rich 
and poor and great inequalities in health outcomes along socio-economic lines (Abdullah, 
2005b; Castro-Leal, 1999; Cummins, 2002). For example, HIV antenatal prevalence rates 
vary in the province from as high as 33% in Khayelitsha to as low as 1.2% in Blaauwberg 
(PGWC, 2005). Moreover, antenatal surveys have shown that there have been greater 
increases in HIV prevalence in urban areas as compared to rural areas, the former of which 
constitute approximately 70% of the provincial population (PGWC, 2002, 2003, 2004 & 
2005). (See Figure 16 on page 35 for maps indicating varying HIV prevalence rates in the 
Western Cape Province). 
As a result of the Cape having stronger health systems due to the legacy of apartheid 
that prioritized service provision in Afrikaner stronghold cities and towns (Coulson et aI., 
1998), the PGWC has been able to speedily target high prevalence urban areas through the 
establishment of ART sites within existing health infrastructures. This already well-
functioning, mainly urban-based provincial health system includes three tertiary hospitals, 36 
district and regional hospitals, 64 community health centres, 252 clinics, 131 mobile clinics 
as well as the highest rates of doctors (72.4) per 100, 000 population and hospital beds (over 
8,000) in South Africa (Abdullah, 2005b). Health provision in the rural areas of the province, 
however, still remains severely constrained. While people are reached by the mobile clinics 
they have to travel enormous distances to the nearest town for sophisticated health 
interventions such as HIV/AIDS treatment (Abdullah, 2005b; Cummins, 2002). Thus, the 
epidemic's spatial progression in the province, concentrated largely in urban settings, is 
facilitating a more effective and swift response. 
A similar trend is now seen in Gauteng (T AC, 2005b) which also has a chiefly urban 
epidemic and, like the Western Cape, a history of the highest spending in public health 
(Benatar, 2004; Castro-Leal, 1999). This is not the case in other provinces. For instance, 
KwaZulu-Natal, which is home to 21 % of South Africa's population, has predominantly rural 
populations (Statistics South Africa, 2003), which, compounded with a history of being 
disproportionately neglected during the apartheid era22 , makes the challenges of ART 
provision much greater. 
22 The entire health budget for KwaZulu-Natal in 1982 was equivalent to the budget of the 
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national epillcl1"'; suggc>t lhal the provincial epidemic is in an earlier phase (PGWc. 10(3) 
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Building Upon the Prevention of Mother-To-Child (PMTCT) Transmission 
Programme and Pilot ARV Sites 
The Western Cape PMTCT initiative served as the frontrunner for the provision of 
ARV triple combination therapy for long-term treatment of adults and children. Most 
informants greatly stressed the importance of this programme in informing the provision of 
ART. Dr. Maartens, a leading HIV/AIDS clinician of Groote Schuur hospital, aptly 
encapsulated this overall sentiment by citing it as the "cornerstone to the success [of the ART 
programme ],,24. 
This project was initiated in 1999 III the township of Khayelitsha that has 
approximately 500,000 inhabitants (Kasper et at., 2003) and current antenatal HIV 
prevalence rates as high as 33% (PGWC, 2005). Khayelitsha is considered to be an 
extremely impoverished area with 50% of its population unemployed and 70% living in 
shacks (Kasper et at., 2003). The government first offered PMTCT in two maternal wards 
providing VCT and ARVs to prevent mother-to-child transmission of HIV during pregnancy 
and labour (Abdullah, 2005b )25. In addition, follow-up care was also instituted at nine clinics 
in the area to provide safety guidance on formula feeding or breastfeeding as well as infant 
HIV testing at nine and 18 months (Abdullah, 2005a). Since 1999, this pilot PMTCT 
programme in Khayelitsha has expanded to become one of the continent's biggest with over 
30,000 women having accepted to be counselled and tested in five years (Abdullah, 2005a; 
Coetzee et at., 2005). Moreover, as a result of this intervention, mother-to-child transmission 
rates have remarkably decreased from 30% (Nattrass, 2004:70) to 5.5% in 2004 (Abdullah, 
2005a). Furthermore, this PMTCT model has now been replicated in 300 antenatal and child 
health clinics across the province including the majority of mobiles (Abdullah, 2005b). 
Almost 100% of eligible patients in the Western Cape now have access to drugs to prevent 
this vertical transmission of HI V (Benatar, 2004). It is also expected that similar reductions in 
transmission rates will be seen throughout the province in 2006 (Abdullah, 2005b). 
24 Maartens, 2006, personal comm., 29 June. 














Building upon this programme, a pilot ART project was launched in May 2001 in 
Khayelitsha. In partnership with Medecins Sans Frontieres (MSF), an international NGO, the 
POWC offered free triple-combination ARVs in three dedicated sites within community 
health services that had already been providing HIV prophylaxis and treatment of 
opportunistic infections: Site B Khayelitsha, Site C Nolungile and Michael Mapongwana 
(Coetzee et al., 2004a; Kasper et al., 2003)26. Mothers and babies who tested positive 
through the PMTCT programme were targeted for ART, and this service was also extended 
to the broader community (Kasper et al., 2003)27. This pilot demonstrated positive health 
outcomes with 86.3% of ARV patients remaining alive after 24 months of treatment --
exceeding survival rates even evidenced in similar interventions in Canada and the USA 
(Coetzee et aI., 2004a; MSF & UCT, 2003). Moreover, no deaths were attributed to adverse 
reactions to these therapies (Coetzee et aI., 2004a; Kasper et al., 2003). As a result of the 
success in Khayelitsha, by December 2003, nine sites in the Western Cape were piloting 
ARV provision (Abdullah, 2005b). The three Khayelitsha sites, however, remained the 
cornerstone of the provincial ART programme: By June 2006, almost 4,500 patients were on 
ARVs in this township -- about a quarter of the total number of people on ART in the 
Western Cape (POWC, 2006). 
This pilot project represented one of the first attempts to integrate ART as part of a 
comprehensive government response to HIV/AIDS in a health district and was hailed by 
implementers as proof that the use of ART at primary health care level in a resource-poor 
setting was safe, feasible and replicable (Coetzee et aI., 2004a; Kasper et al., 2003; MSF & 
UCT, 2003; WHO, 2003)28. Dr. Cloete29 of the POWC reflects that this formed the impetus 
for further expansion of ART in the province noting that: 
"We had piloted the thing since 2001, and we built up collective experience of how to 
do a treatment programme, and a lot to do with that is the experience we built up 
specifically in primary care in Khayelitsha with the MSF site." 
26 Goemaere, 2006, personal comm., 18 July. 
27 Goemaere, 2006, personal comm., 18 July. 
28 Cloete, 2006, personal comm., 8 August; Goemaere, 2006, personal comm., 18 July; Naidoo, 2006, 
personal comm., 7 August. 













Moreover, some believe that this success sent a strong signal to other provinces and national 
government that had been claiming that provision of such a service was unattainable in a 
context like South Africa. It is important to note, however, that these projects -- while 
implemented in a resource-constrained environment -- were actually resource-intensive 
during the pilot phase with ample donor funds and human resources. Many at the time called 
into question the feasibility oflarge-scale replication of such a resource-rich model. 
Nevertheless, the highly successful PMTCT programme and pilot ART sites offered 
many valuable lessons and insights from which to expand ART provision. Firstly, they 
allowed the provincial government to establish expertise in the procurement and management 
of the supply chain of ARVs as well as in their administration (Abdullah, 2005b). More 
specifically, the PMTCT programme in Khayelitsha illustrated that complex regimens could 
be delivered effectively on a large scale within primary health care services (Coetzee et al., 
2005). Secondly, these projects permitted for training and building of skills at the clinic level 
in effective ways to deliver ART services (Abdullah, 2005b; Kasper et al., 2003). Finally, 
the pilot ART project demonstrated that because patients on ARVs can experience rapid 
improvements in their health, follow-up could be done by nurses instead of doctors (Kasper 
et al., 2003). In tum, these positive health outcomes in patients were also shown to greatly 
boost health care practitioners' morale (Kasper et al., 2003)30. Thus, the introduction of ART 
could potentially be seen as an opportunity to begin to address fundamental problems within 
the health care system such as provider attitudes (Schneider & Coetzee, 2003). With this 
wealth of experience in ARV provision, the Western Cape was well-placed to extend this 
service to other sites when the national government announced the Operational Plan. 
While the Western Cape had a head-start compared to other provinces, there has been 
much learning that can be extrapolated to other provincial settings. In particular, established 
protocols, assessment tools, guidelines and training materials for health care providers and 
counsellors can be adapted for other provinces in the absence of national directives in certain 
areas. Lessons concerning management of case loads and how responsibilities can be 
delineated between doctors and nurses as well as strategies to address human resources 
shortages and fatigue are also important. 











Building Effective and Successful Partnerships 
One of the most pertinent lessons from the PMTCT programme and pilot ART project 
has been the importance of involving partners in implementation. For phasing in the ART 
expansion, the Western Cape provincial government out sourced the entire counselling 
component to NGOs (though this would be provided on-site), established strong links with 
TAC to ensure community involvement and treatment literacl l at most of the metro-based 
services, and cultivated partnerships with other NGOs, local authorities and clinicians from 
academic hospitals and universities (Abdullah, 2005b). Building upon the MSF example, 
ART sites were also established in partnership with the Desmond Tutu HIV Centre (in 
Gugulethu and Masiphumelele) and Kidzpositive (at Groote Schuur Hospital) (Abdullah, 
2005b)32. Other operational research projects were also pursued hand-in-hand with NGOs 
and university hospitals to determine best practices in the provision of ARVs in the public 
sector (Abdullah, 2005b )33. 
These partnerships and their associated funding were critical in the pilot phase when 
there was still no national policy for the provision of ART through the public sector (Naimak, 
2006; Nattrass, 2006a). Dr. Maartens34 of Groote Schuur hospital notes that: 
"The key to our success was in a sense political in that there was enormous 
reluctance on the part of the state to start PMTCT and ART The way that the local 
government got around the national government's reluctance to do this was to set up 
pilot sites [with partners}, to pretend, in a sense, that it was research or a study. It 
wasn't entirely a pretence because if you are going to start a new intervention it is a 
good idea to start it at a centre. National government were supportive of [these 
partnerships}. " 
31 T AC (2003) defines their treatment literacy programmes as including discussions on safer sex, 
nutrition, mother-to-child transmission prevention, post-exposure prophylaxis, treatment of 
opportunistic infections, accessing social grants, conditions in the public health service and 
antiretroviral therapy. 
32 Cloete, 2006, personal comm., 8 August. 
33 Cloete, 2006, personal comm., 8 August. 
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Further, Dr. Goemaere35 ofMSF comments that: 
"[The first ARV project with MSF} was called private research in a public facility to 
see if it works. It was a crazy kind of thing. When you put things under operational 
research you are basically allowed to do what you want as long as it is an ethical 
approach - which we had." 
As such, these organisations enabled the pilot process to proceed when the PGwe could not 
'advertise' such a programme nationally and also allowed for important research to be 
conducted on how to implement ART programmes at the primary care level. Moreover, Dr. 
Boulle of veT observes that these services, although partly or fully run by partners still, are 
seen as government programmes -- allowing for the continuation of vital research outputs 
while actually providing life-saving health services to communities36• 
A particularly noteworthy partnership has been with an NGO called Absolute Return 
for Kids (ARK). This collaboration aims at speeding up accreditation of new ART sites to 
expand access in more areas. ARK instantly upgrades the potential site's capacities by 
supplying medical experts in ART on a short-term basis with the view that the PGWe will 
secure appropriate permanent staff within a few years as well as improve the site's overall 
health systems (Abdullah, 2005b). Dr. Grimwood37 of ARK notes that: 
"[ARK} pays for staffing costs, [and} works longer in this area [of human resources}, 
because the province could not get the staff we could, and [we} move our staff around 
[different sites} in the SWAT team approach .. .[ARK} trains staff [and recruits them} 
locally from the private sector, we've taken people out of retirement. We pay the 
same rates, the same level that government is paying .... so then the issue of the 
province taking over and sustainability is not put at risk ... when we exit. We have 
encouraged our staff to apply for government positions, which has happened and has 
been successfitl." 
35 Goemaere, 2006, personal comm., 18 July. 
36 Boulle, 2006, personal comm., 27 JUly. 






















Significantly, this approach, thus, ensures that human resources are strengthened and that no 
existing DOH employees are removed from their present positions since recruitment takes 
place from the private sector and retried personnel. Moreover, by using contracts that are on 
par to government, the ultimate retention of trained and skilled staff within the PGWC is 
ensured -- unlike most donor-funded programmes that offer higher salary scales. To date, 
ARK has provided this kind of technical assistance to 22 ART sites in the Western Cape38 --
half of all existing sites that are currently providing ARVs in the province. 
This is a model that would be highly recommended for other provinces. Given the 
shortage of human resources in the public health system (ITPC, 2006; Kober & Van Damme, 
2004; McCoy et al., 2005; Schneider & Coetzee, 2003; TAC, 2005a, 2005c & 2006b), and 
more particularly, experts in ART (TAC & ALP, 2004 & 2005), the need to share expertise in 
ARV provision across the provinces is essential if South Africa is to successfully roll-out a 
national HIV/ AIDS treatment programme. Moreover, rapidly addressing human resource 
shortages is considered one of the key challenges in scaling-up HIV / AIDS treatment 
(Institute of Medicine, 2004; Kovsted, 2005) and this model offers an innovative solution. 
With the expansion of its work to other provinces, namely the Eastern Cape, KwaZulu-Natal 
and Mpumalanga, ARK is now using the Western Cape sites as 'training grounds' for other 
recently recruited ART personnel from across South Africa39. 
In addition, the Western Cape holds regular public briefings on the rollout of ART to 
ensure widespread stakeholder involvement (TAC & ALP, 2004)40. This participation of 
civil society has created an environment of "openness and unity" -- lending credibility to the 
PGWC and its political willingness to expand access to ART (Naimak, 2006:19). While 
there are certainly tensions within the PGWC's partnerships, most partners perceive the 
programme as inclusive. Importantly, infonnants all noted that this is one of the key factors 
that have facilitated the speedy expansion of the programme -- allowing the PGWC to 
capitalize on the cumulative knowledge and expertise of all implementing and research 
partners. In addition, this team effort approach to implementation has enabled the province 
to attract good quality staff and generate greater resources (Abdullah, 2005b:258)41. 
38 Grimwood, 2006, personal comm., 10 July. 
39 Grimwood, 2006, personal comm., 10 July. 
40 Slingers, 2006, personal comm., 9 August. 















Finally, in an effort to ensure a programme that is sustainable, the PGWC regularly 
holds discussions with partners concerning the takeover of operations by the provincial 
government within realistic time-frames (usually three to five years)42. This is a critical 
strategy in the province that has allowed for the immediate scaling-up of treatment provision 
while the provincial government strengthens health systems and builds a pool of trained 
human resource expertise in this area. For example, while the three sites in Khayelitsha were 
initially fully run by MSF, the PGWC began to take this over in 2005, in particular the supply 
of the ARV s and the recruitment of doctors and nurses (T AC, 2006a)43. Full responsibility of 
the ART programme in Khayelitsha will be assumed by government by 200844. In addition, 
after three years, ARK is now in the process of exiting from the 22 ART sites in the Western 
Cape where it has provided medical experts and systems strengthening, and the provincial 
government is taking on these functions and some of the staff5. Such strategies would greatly 
assist other provinces in jump-starting their scale-up campaigns (T AC & ALP, 2005). 
Strategies that are Ensuring High Rates of Adherence 
Adherence to ART is well-recognized to be a critical component of individual and 
programmatic treatment success (WHO, 2004a). If patients do not successfully take their 
medications, not only will they have negative health outcomes but they are likely to develop a 
drug-resistant strain of HIV (ibid). In such a scenario, if an individual chooses to attempt 
treatment again and fails to respond to the existing options in first-line and second-line 
regimens46, they would have exhausted all treatment possibilities (ibid). From a 
programmatic perspective, second-line drugs are still largely unaffordable for governments 
(MSF, 2005). If large numbers of patients stop and start their ART, and, thereby, develop 
drug resistant strains requiring second line treatments, the ART projects may no longer be 
affordable and sustainable. Furthermore, patients who develop drug resistance are at risk of 
spreading the resistant virus, thus threatening the treatment potential of new patients entering 
the programme (Abdullah, 2005b). Lack of adherence to life-long HIV/AIDS drug therapies, 
and the subsequent widespread development of community-acquired resistance47 -- also 
42 Cloete, 2006, personal comm., 8 August. 
43 Goemaere, 2006, personal COmill., 18 July. 
44 Cloete, 2006, personal comm., 8 August; Goemaere, 2006, personal COmill., 18 July. 
45 Cloete, 2006, personal comm., 8 August; Grimwood, 2006, personal comm., 10 July. 
46 First line regimens are followed and in the case of adverse side effects or acquired immunity, 
second line regimens are pursued (Kovsted, 2005; WHO, 2004a). 
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known as the feared "tsunami of resistance,,48 -- place the public health benefits of a 
treatment programme at great risk. 
Studies of the ART sites in the Western Cape have shown that adherence is not a 
barrier to successful ART in South Africa (Bekker et aI., 2006; Coetzee et at., 2004a; Kasper 
et at., 2003; Orrell et at., 2003; WHO; 2003)49. This has been evidenced by the proportion of 
individuals on treatment who are achieving viral suppression and matches results seen in 
North America and Europe (Bekker et aI., 2006; Orrell et at., 2003). Moreover, it has been 
found that socio-economic status as well as sex and HIV stage does not predict adherence 
(Orrell et at., 2003)50. This is an extremely critical finding given some concerns that have 
been articulated internationally that poor Africans cannot adhere to ARV treatment (Kovsted, 
2005; Orrell et at., 2003)51. In addition, a recent research study in Gugulethu demonstrated 
that rapid scale-up of ART within an urban South African setting did not have adverse effects 
on programmatic outcomes (Bekker et at., 2006). Thus, the Western Cape public sector ART 
programme is in the forefront of demystifying global perceptions about delivery of ART and 
adherence to medications in resource-constrained contexts. Projects in Brazil, Haiti, Uganda 
and Senegal are also contributing to this growing body of work (Coetzee et at., 2004a; Egger 
et at., 2005; Farmer et at., 2001; Orrell et at., 2003). 
To ensure high adherence and retention in care rates, the PGWC is implementing 
several community-based psycho-social support models. While research on best practices in 
this area is still on-going (Abdullah, 2005b), they are all based on a patient-centred education 
approach combined with community involvement and/or facility-based support (Pienaar et 
at., 2006). Central to these models is the understanding that stigma associated with 
HIV / AIDS may discourage people from getting tested, starting ART and continuing 
treatment (Stewart et at., 2004), and that government and community leaders should create a 
programme (WHO, 2004a). In the USA and Europe, approximately 10% of new HIV infections 
involve viral strains that are resistant to at least one drug (ibid). 
48 Mthathi, 2006, personal comm., 17 July. 
49 Grimwood, 2006, personal comm., 10 July; Maartens, 2006, personal comm., 29 June; Wood, 2006, 
personal comm., 7 August. 
50 Three times daily therapy was the strongest predictor for poor adherence (Orrell et aI., 2003). This 
result is found in other countries as well and is the impetus for pushing pharmaceuticals to produce 
triple combination (Fixed Dose Combination) HIV / AIDS drugs that need to only be taken twice a day 
(MSF, 2004; WHO, 2004a). 
51 Jones (2004) outright dismisses this notion as a reflection of a prejudicial general perception that 


















culture of openness and support to counteract this (Institute of Medicine, 2004; WHO, 
2004a). In Khayelitsha, this has involved the selection of a treatment coach who becomes the 
main individual in psycho-social support, backed by site-based counsellors and regular 
support groups (Coetzee et aI., 2004a)52. In Gugulethu, lay counsellors are community-
based, doing home visits and unannounced pill counts, as well as working with clinic staff in 
patient management for as many as 30 patients (Abdullah, 2005b; Bekker et al., 2006). At 
the Tygerberg Hospital, patients are counselled by site-based counsellors and referred to 
home-based care organisations for psycho-social support in the community (Abdullah, 
2005b). This latter example represents an innovative way of utilizing capacity in this existing 
sector, particularly as the need for home-based care decreases as more patients are on ART. 
ARK has developed a Patient Advocate model that involves psycho-social support from both 
the patient advocate (a nominated community member) as well as a 'treatment buddy' (a 
friend or relative), and includes a system of home visits, an array of adherence tools such as 
the 'pill box' and is backed by on-site counsellors and support groupS53. The Patient 
Advocate manages 20 patients in the first six months (the "TLC" high maintenance period at 
the on-set of therapy) and, once treatment adherence has stabilized, expands this to 70 
patients. In all these cases, T AC plays a central role mobilizing the community and 
conducting treatment literacy campaigns for patients as well as the broader public (Abdullah, 
2005b; Coetzee et aI., 2004a; TAC, 2003, 2004 & 2005a). 
The particular role of TAC in ensuring high adherence rates at ART sites in the 
Western Cape metro areas deserves special attention. Treatment literacy has shown to be a 
powerful tool to community mobilization because it not only offers education on health care, 
HIV and HIV / AIDS medicines, but also on human rights, the politics of treatment access and 
activism (TAC, 2005a; WHO, 2003). In communities where HIV/ AIDS stigma is 
widespread, this knowledge can be transformative, enormously increasing confidence and 
often overall well-being as well (TAC, 2005a; WHO, 2003). At the cornerstone of this 
activity is that education and awareness is targeted at both potential ART patients within the 
health care setting as well as the surrounding community at large54. Moreover, research 
indicates that where TAC grassroots activities are most concentrated, ART and PMTCT 
uptake is high (Robins, 2004; TAC & ALP, 2004). This would suggest that TAC's health 
52 Goemaere, 2006, personal comm., 18 July. 
53 Grimwood, 2006, personal comm., 10 July; Jason, 2006, personal comm., 10 July. 
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activism is contributing to countering socio-cultural barriers to access to treatment including 
HIV/AIDS fear and stigma. For example, a study of nine commuter sites across South Africa, 
including Khayelitsha, found that Khayelitsha residents had the highest levels of HIV testing, 
desire to be tested, condom use and willingness to join an AIDS club (Parker et al., 2002). 
While this is certainly attributable to the provincial government's comprehensive approach to 
HIV/AIDS care in this township, the significant role of TAC in Khayelitsha is well-
documented and widely acknowledged (Kasper et ai, 2003; MSF & VCT, 2003; Robins, 
2004; WHO, 2003)55. Robins (2004:666) argues that TAC's successful grassroots 
mobilization has introduced "new concepts of health citizenship" in South Africa within the 
politics of class and access to essential life-saving medicines. That is, politicizing the right to 
health care has empowered South African citizens. As the need for treatment literacy grows 
with hospitals and clinics expanding ART services in other provinces, TAC has now shifted 
its national focus to assume greater responsibility at the provincial and district levels (Robins, 
2004; TAC, 2005a)56. Lessons from TAC's activities in the Western Cape should be applied 
to other provinces that are not fully engaging with this organisation as yet. 
When considering the role of T AC and the psycho-social support models being 
implemented in the Western Cape ART programme, a new kind of contract appears to be 
materializing between patients and health care providers. As Schneider and Coetzee (2003: 1) 
note: 
"This contract is premised on very high levels of understanding, treatment literacy 
and preparation on the part of users, the establishment of explicit support systems 
around users, and community advocacy processes that promote the rights of people 
living with HIVIAIDS. The responsibility for adherence is given to the client within a 
clear framework of empowerment and support." 
This translates into more time and resources than is typical in a current patient and health 
worker relationship (Kovsted, 2005). Each of the support models outlined above have 
different implications from financial and human resources perspectives (Pienaar et ai., 2006). 
There is a need for further evaluation of these options to determine the most effective, 
efficient and sustainable approach as the programme continues to expand and patient 
55 Goemaere, 2006, personal comm., 18 July; Naidoo, 2006, personal comm., 7 August; Toms, 2006, 
personal comm., 13 July. 
56 TAC now has six provincial offices based in the Western Cape, Gauteng, KwaZulu-Natal, Eastern 
Cape, Limpopo and Mpumalanga and five district offices all of which are served by volunteers who 
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numbers increase. Furthermore, when determining the most suitable model of care it is 
important to also ensure that it will have broader applicability within delivery of primary 
health care services -- a view touted by the PGWC and the City of Cape Town -- providing 
support for adherence to medications for other infectious and chronic diseases, such as TB 
and diabetes57. This learning is critical to ensure health systems strengthening and continued 
success in this area in the Western Cape, as well as for other provinces that are only now 
beginning scale-up activities. 
Finally, while WHO as well as the National Antiretroviral Treatment Guidelines 
strongly recommend extensive psycho-social support mechanisms as are implemented in the 
public sector roll-out in the Western Cape (DOH, 2004; WHO, 2004a), there is some 
indication from the Western Cape that high adherence rates can be maintained without these 
extensive measures of support. A study conducted amongst 289 patients presenting at the 
University of Cape Town's (UCT) HIV clinics, which serve largely indigent popUlations, 
revealed that adherence to ART was 93.5% in the absence of any dedicated adherence 
counselling service, structured adherence support or formal adherence intervention (Orrell et 
al., 2003). This directly challenges arguments that ART must be delivered in resource-poor 
contexts with extensive adherence support mechanisms58 • With the public health risks being 
so high in the event of low adherence rates to HIV / AIDS medicines, it is well-founded that 
the PGWC (as well as the national and global responses) are exercising caution by instituting 
extensive support systems. Furthermore, these support systems are addressing broader socio-
cultural barriers and stigma that permeate beyond adherence to drugs. Nevertheless, the 
findings from UCT's HIV clinics offer the possibility for successful adherence rates across 
South Africa, particularly in largely rural provinces such as the Eastern Cape, KwaZulu-Natal 
and Limpopo that are constrained by weaker health systems and poorer access to health care 
by their populations59 (Castro-Leal, 1999) -- all inhibiting factors in the provision of resource 
intensive support systems that actively link clinics with communities. 
57 Cloete, 2006, personal comm., 8 August; Toms, 2006, personal comm., 13 July. 
58 For example, Wendo (2003) and Farmer et al. (2001) promote a Directly Observed Treatment 
(DOT) strategy for HIV/AIDS treatment by paralleling this to the management of Multi-Drug 
Resistant Tuberculosis in resource-poor contexts through a longer term "DOTS-Plus" intervention. 
(Directly Observed Treatment Short-course (DOTS) of Tuberculosis is a strategy that involves 
political commitment, good quality diagnosis, good quality drugs, short-course chemotherapy given 
under direct observation and systematic monitoring and accountability (WHO, 200Sc).) 













Leadership and Management Model 
At the core of the Western Cape ART's scale-up and success has been strong 
leadership and management at the provincial government level (N aimak, 2006) -- a model 
heralded by all implementation partners as best practice and warranting replication in other 
provinces. The political will to ensure access to HIV / AIDS treatment in the province has 
been firmly demonstrated through the commitment of provincial government financial 
resources to this effect, as well as the inclusion of all role players and partners in programme 
design and implementation. In particular, Dr. Grimwood6o of ARK reflects that: 
that: 
"[The programme} was established [by the PGWCj on a modicum of trust with the 
implementing partners, that was built on previous relationships and [was} not 
coming with a political agenda, and [was} not coming with a research agenda." 
When referring to scale-up of ART programmes, Schneider and Coetzee (2003:1) note 
"Political management is as important as technical design. The process of 
implementation needs to [be} supported by a rigorous communication strategy aimed 
at preparing and ensuring the buy-in of all the actors who will be implicated in the 
process of implementation." 
The Western Cape provincial government has worked to achieve this by bringing together 
both managers and clinicians from the beginning into a common decision-making structure 
that meets regularly and determines the policy directions of the programme (Abdullah, 
2005b )61. As new sites are opened in the province, those managers and health care 
practitioners join this structure, as do partners (ibid). The goal has been to consistently marry 
the challenges between delivery of treatment to patients with managerial issues such as 
budgets, human resources and procurement and supply chain management. The PGWC 
observe that this management model has fostered a detailed level of planning, transparency 
and, more importantly, joint ownership in addressing problems as well as in claiming credit 
for the successes of the programme (ibid)62. All informants noted that this has resulted in a 
"can do" approach to implementation that is seen at all levels -- from management to 
clinicians. 
60 Grimwood, 2006, personal comm., 10 July. 
61 Slingers, 2006, personal comm., 9 August. 














Moreover, Dr. Fareed Abdullah, fonner Deputy Director General and Head of the 
AIDS programme in the Western Cape Province, was praised by most infonnants for his 
brave leadership and was attributed as the force behind the programme's standing success. 
He has been perceived by some as not only having the courage to begin the first PMTCT 
programme in 1999 -- against national policies at the time -- but also the vision to enter into a 
partnership with MSF to initiate research on implementation of ART at the primary care level 
(Naimak, 2006). In addition, Dr. Abdullah had the foresight in 2003 to apply to the GF ATM 
for a grant -- subsequently generating substantial resources for the province that have greatly 
facilitated the successful scale-up of ART in the Western Cape (ibid). Dr. Maartens63 of 
Groote Schuur hospital reflects on the role that Dr. Abdullah has played: 
"He saw the need, drove the programme, [and} worked the system. [He} didn't break 
any rules and was smart. He took ownership of things instead of having donors 
parachuting in and out." 
Dr. Goemaere64 ofMSF also pertinently comments that: 
"Fareed was the real driver behind [the programme} ... Fareed was the visionary." 
63 Maartens, 2006, personal comm., 29 June. 

















Key Challenges Confronting the Western Cape 
HIV/AIDS Treatment Programme 
While the South African ARV programme has been acknowledged by the Joint Civil 
Society Monitoring Forum65 (JCSMF) as succeeding in many respects, it has been noted that 
"it needs to be infused with a permanent sense of urgency to drastically increase the numbers 
on treatment and to strengthen health resources and systems" (JCSMF, 2006b:l). A recent 
study assessing the availability and utilization of HIV services across South Africa revealed 
that the process of scaling-up ART is seemingly accentuating historic inequalities in health 
care access with poorer areas unable to effectively scale up the response even with the 
availability of extra resources (Scott et ai., 2005). In this context, it is widely acknowledged 
that in order to effectively address issues in equity of access and, thus, reach public health 
goals, a wider strengthening of health systems is required (EQUINET, 2004; McCoy, 2003). 
Moreover, unless policy makers attend to issues of equity, otherwise efficient public health 
HIV/ AIDS treatment interventions may prove to be of limited effectiveness (Scott et ai., 
2005) with limitations in access to care having a major impact on ART programme outcomes 
(Pienaar et ai., 2006). Policy directions on ARV allocation are critically important given that 
these decisions essentially determine who will live and who will die. In order to achieve 
public health goals and foster accountability, it is imperative that an open public policy 
debate and a fair process is conducted to inform the selection of such polices, and that any 
trade-offs in equity in access are made transparent and actively deliberated by all 
stakeholders (Daniels, 2005; McCoy, 2003; Rosen et aI., 2005). 
65 Launched in 2004, the Joint Civil Society Monitoring Forum consists of civil society organisations 
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In the following sections, I will discuss these two intertwined challenges that are 
confronting the Western Cape programme in the medium and long-term: Ensuring equitable 
and universal access to ARVs and achieving health systems strengthening. It is important to 
note that while there were a limited number of treatment slots during the pilot phase of the 
ART programme -- necessitating a triage approach to implementation -- as the programme 
now expands towards universal access, this, in theory, should no longer be a constraint. In 
this context, this research has identified a number of policy and implementation gaps that 
could hinder the ultimate realization of the goal of universal access. While the reality on the 
ground is that the capacity to scale-up still remains a challenge in the province -- resulting in 
the continuing use of rationing systems -- as the POWC now enters its second phase of 
expansion towards universal access, the gaps in achieving equitable access generated from 
this research become of the utmost importance. Moreover, given the Western Cape's longer 
history in implementing ART, many insights can be drawn from these to inform policy 
directions and implementation in other provinces. 
For the purposes of the ensuing discussion and analysis, the following definition of 
equity as it relates to health will be utilized (Stewart et aI., 2004:51): 
"The absence of potentially remediable, systematic differences in one or more aspects 
of health across socially, economically, demographically, or geographically defined 
population groups or subgroups. Seeking equity in health implies addressing 
differences in health status that are unnecessary, avoidable and unfair." 
Fostering Eguitable and Universal Access to ARVs 
The POWC has shown that a universally available HIV/AIDS treatment programme is 
within reach in South Africa (Abdullah, 2005a & 2005b). By December 2005, 55.7% of 
adults and children that are estimated to need ART treatment in the province were under-
going therapy (Nattrass, 2006a). Furthermore, it is expected that coverage rates for children 
will surpass 90% in 2006 as a result of the massive decrease in childhood infections 
attributable to the PMTCT programme (Abdullah, 2005b). However, with the Western Cape 
Province needing to expand the programme four-fold in the next five years to prevent an 
increase in morbidity and mortality (Pienaar et al., 2006), increasing coverage, enrolling new 
patients on ART and equitably reaching the diverse range of populations in the province that 













F or one, the Western Cape Province is nearing its full capacity of treatment numbers 
that the current national-approved budget of the 2006-2007 PGWC Business Plan will allow 
for -- a maximum of approximately 22,500 patients (POWC & UCT, 2006). Partners note 
that there is, hence, an urgent need for an increase in budgetary allocation in this area from 
national government as well as from other provincial and external sources if possible66 . The 
POWC, however, remain confident that this will not be a constraint to expanding access. Dr. 
Cloete67 of the POWC notes that: 
"It's fine. I have got no problem with that. We have a clear process [with national). 
And I think the process that we engage in with national is a good one and it is very 
clear. So I am not particularly over worried about that process." 
Nevertheless, this impending negotiation with national government vis-a-vis the budget 
remains the key determinant of the POWC's ability to further expand treatment and coverage. 
In addition, T AC observes that the strict national guidelines for the accreditation of 
ART sites are posing a further barrier for expanding access and that they need to be re-visited 
within national dialogues68 . While other informants did not identify this as a barrier to 
expansion, accreditation of sites has been documented by some as slowing the 
implementation process in different provinces (Abdool Karim & Abdool Karim, 2005; 
Abdullah, 2005b; TAC & ALP, 2004 & 2005). 
At the provincial level, current programme strategies are still challenged to reach all 
those that need ART in the province. To consider this, in the following sub-sections key 
strategies that the POWC has employed will be discussed, namely, the selection of ART sites, 
the criteria for choosing patients, whether men and women are being appropriately targeted 
and reached as well as the programme's nutrition component. For this analysis, it is 
important to note that the Western Cape Provincial Antiretroviral Treatment Protocol has 
patient selection criteria in line with the National Antiretroviral Treatment Guidelines. This 
includes, in addition to clinical eligibility for treatment, the collective consideration of further 
criteria such as geographical access to the site, disclosure, past history of adherence, alcohol 
66 Boulle, 2006, personal comm., 27 July; Hassan, 2006, personal comm., 11 July; Mthathi, 2006, 
personal comm., 17 July; Toms, 2006, personal comm., 13 July; Wood, 2006, personal comm., 7 
August. 
67 Cloete, 2006, personal comm., 8 August. 
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and drug dependency and mental state (Provincial Administration Western Cape, 2004:4-S). 
Furthermore, while not explicitly stated in the Antiretroviral Treatment Protocol, Dr. 
Abdullah, former Deputy Director General of the PGWC, has documented that literacy levels 
are also being considered as eligibility requirements in the PGWC ART programme 
(Abdullah, 200Sa & 200Sb:2S3). In theory, none of these criteria are supposed to be 
exclusive and an assessment of the patient is done by the clinical team before a decision is 
made (Provincial Administration Western Cape, 2004). 
Geographical Access 
The provincial government has taken a strategic approach to scaling-up ART by 
limiting the number of ART sites to 40 or SO in secondary Community Health Clinics 
(CHCs) and tertiary hospitals. The basis for this lies in that sufficient technical expertise 
does not exist at every clinic, community health service and hospital, so the government has 
opted for pooling expertise and focussing management and training on a more manageable 
number of sites (Abdullah, 200Sb). Using this strategy, the PGWC has been able to reach as 
many people as possible in the shortest amount of time. Moreover, by limiting the number of 
practitioners prescribing ARVs, it is hoped that "liberal prescribing practice" will be averted 
and that the criteria for selection of patients will be more closely followed (Abdullah, 
200Sb:2S3). This approach essentially aims to prevent drug resistance in patients (and, thus, 
the wider community), by ensuring that patients that are most likely to adhere to treatment 
and be retained in care are selected for ART. 
Furthermore, in an effort to promote equitable geographical access to ARVs while 
meeting public health goals, the decision as to where to open sites has been guided by 
antenatal prevalence rates in the province (with emphasis on high prevalence areas), existing 
expertise and infrastructure as well as geographicallocation69 . For example, while the West 
Coast of the province is under-populated with lower prevalence rates, given the lack of 
clinics in these areas some ART sites have, nonetheless, been opened in the region7o. 
Moreover, the PGWC observe that nearly every sub-district in the province has coverage 
with at least one ART site7!. 
69 Maartens, 2006, personal comm., 29 June; Osler, 2006, personal comm., 30 June; Slingers, 2006, 
personal comm., 9 August. 
70 Osler, 2006, personal comm., 30 June. 
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Many scholars recognize that the scale-up of ART programmes must be initiated in 
better equipped and resourced hospitals and clinics (that are usually urban-based), and then 
expanded as fast as possible to other areas (Geffen et at., 2003; Kovsted, 2005; Nattrass & 
Geffen, 2003; Stewart & Loveday, 2005; WHO, 2004b). While this may contribute to 
worsening existing health inequalities, it is often seen as an initial unavoidable consequence 
of going to scale (Kovsted, 2005; Ntuli et al., 2003; Stewart & Loveday, 2005). In the 
Western Cape, prospective ART patients that live far from the limited number of designated 
sites, particularly in rural areas, are at a great disadvantage when it comes to accessing 
treatment and continuity of care (Abdullah, 2005b) 72. Furthermore, T AC and the AIDS Law 
Project (ALP), in monitoring the implementation of the PGWC programme, also observe that 
this is a particular problem for children needing treatment. Ms. Hassan 73 of ALP notes that: 
"The whole issue of secondary and tertiary sites being the main nodes of treatment is 
a particular problem for children. if you look at the numbers of children on treatment 
most of them are concentrated in four, big urban hospitals. The issue then is what 
about children who can't access those four sites?" 
Moreover, even when prospective patients do present at one of the ART sites and are eligible 
for treatment from a clinical perspective, they may not be accepted in the programme for fear 
of low adherence given the need for regular follow-ups and their lack of proximity to the 
health service. Until the PGWC is able to effectively extend ART sites to these areas, it is 
critical that this programme address logistical issues, such as transportation, child care and 
time away from income-generating activities, in order to remove the barrier of physical 
isolation and ensure that all eligible patients can have access to these life-saving drugs 
(WHO, 2004b). Addressing transport barriers for rural populations is also stipulated in the 
Antiretroviral Treatment Protocol. In the absence of this, limiting the number of service sites 
will favour those who live nearby as well as households that have the resources to travel 
(Rosen et at., 2005). 
72 Cloete, 2006, personal comm., 8 August; Goemaere, 2006, personal comm., 18 July; Hassan, 2006, 
personal comm., 11 July; Mthathi, 2006, personal comm., 17 July. 
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To date, no fonnal guidelines for enabling the policy of providing transport for far-
flung communities have been developed in the Western Cape74 . Dr. Grimwood75 of ARK 
notes that: 
"Means of access to get transport support, to get your hospitals to waive the [clinic 
user} costs -- people still get charged -- [are lacking]. There is a lack of information 
on the ground and a lack of guidelines. The policy has not been translated into 
guidelines. " 
Ms. Hassan 76 of the ALP further elaborates on the challenge of paying transport costs to 
reach distant ART sites as well as clinic user fees: 
"There is transport, which nobody is addressing and nobody is attending to, and then 
there is the issue of user fees where people have to pay up to R70-75 per visit if they 
[are employed}. So some people are getting billed for the treatment [and paying 
transport costs}. " 
While the PGWC cites some examples in a few districts of using ambulances to bus 
patients to ART sites for HIV/AIDS services one day a week77, or TAC getting local 
businesses to help provide transport78 , these are, however, not sustainable and feasible long-
tenn solutions. Until ART is made more available at the community level and additional 
sites are opened, inaccessibility due to distance will persist as a key barrier in achieving 
equitable and universal access. With the restructuring of the health care system in the 
Western Cape Province in line with the Comprehensive Service Plan for Health Care 2010, 
the PGWC now plans to focus on decentralizing ART sites to the district level in the hope 
of removing this barrier79• Nevertheless, in the interim, guidelines to enable the transport 
policy should be pursued to allow for more eligible patients to access this service, as well as 
to ensure that patients are not unduly paying for both transport and clinic user fees. 
74 Goemaere, 2006, personal COtnm., 18 July; Grimwood, 2006, personal comm., 10 July; Hassan, 2006, 
personal comm., 11 July; Maartens, 2006, personal comm., 29 June; Mthathi, 2006, personal cotnm., 
17 July; Naidoo, 2006, personal comm., 7 August; Toms, 2006, personal comm., 13 July. 
75 Grimwood, 2006, personal comm., 10 July. 
76 Hassan, 2006, personal comm., 11 JUly. 
77 Osler, 2006, personal COtnm., 30 June; Slingers, 2006, personal COtnm., 9 August. 
78 Mthathi, 2006, personal comm., 17 July. 
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In addition, the Western Cape Province is facing other challenges III reaching 
vulnerable groups with ART provision due to geographical barriers and the limited 
selection of ART sites. For example, the ALP has identified that most prisoners in the 
province are not getting effective access to HIV I AIDS treatment and that prison hospital 
clinics have not been prioritized for accreditation -- despite the public health HIV/AIDS 
crisis being seen in South Africa's jails80. While prisoners might be transported to some 
outside accredited facility for ART occasionally, those that are waiting trial and cannot afford 
or are denied bail have no access at all and often spend long periods in this judicial limbo, 
while their health deteriorates gready81. This would point to the need for prison facilities to 
be prioritized for accreditation as the province continues its roll-out campaign. 
Furthermore, there is a challenge in ensuring continuity of care and adherence in 
patients who regularly move between neighbouring provinces. For example, partners 
observe that there is a large population of people from the Eastern Cape who move to Cape 
Town for work but go back to the Eastern Cape for several months every year82. While 
potentially administratively cumbersome, Dr. Toms of the City of Cape Town DOH and Prof. 
Wood of the Desmond Tutu HIV Centre consider the need to institute a cross-provincial 
system that allows patients to begin treatment in one province and continue to receive 
medications and counselling in another -- even if just temporarill3. Dr. Toms notes that: 
"We have acknowledged [this challenge] at the nationalleve!. The need to be able to 
find a way to relate that. In a sense, we could maybe phone the clinic [in the Eastern 
Cape] or warn them or somewhere make sure that the connection happens. Because 
it is not happening even in TB -- let alone ART." 
Such a system, however, would necessitate political will at provincial levels as well as 
effective tracking systems within ART delivery services in both provinces. 
80 Hassan, 2006, personal comm., 11 JUly. 
81 Hassan, 2006, personal comm., 11 JUly. 
82 BoulIe, 2006, personal comm., 27 July; Grimwood, 2006, personal comm., 10 July; Maartens, 
2006, personal comm., 29 June; Toms, 2006, personal comm., 13 July; Wood, 2006, personal comm., 
7 August. 






















Patient Selection Criteria 
When considering equity in access to treatment, it is important to interrogate some of 
the psycho-social patient selection considerations in the treatment guidelines. In particular, 
while the many benefits of having the active support of a 'treatment buddy' of sorts are 
widely acknowledged in ensuring continuity of care for ART patients, the strongly 
recommended disclosure criterion raises some concerns. Firstly, and foremost, by evoking 
disclosure in an environment burdened by stigma and discrimination84, many people may not 
voluntarily come forward to get tested and to accept treatment (Stewart et at., 2004; Van Dyk 
& Van Dyk, 2003)85. While some research studies are beginning to reveal how PLWHA are 
negotiating positive experiences of disclosure, addressing stigma and gaining support in a 
productive manner (Almeleh, 2004; Kahn, 2004), stigma and discrimination persists as a 
challenge in most communities. Secondly, such a criterion for consideration for treatment 
creates inconsistency and inequity between ART provision in the public sector as compared 
to in private practice where there is no disclosure policy. Since the public sector serves 84% 
of the population consisting mainly of the uninsured and poor (Health Systems Trust, 2005), 
this, in effect, creates a disparity where those of higher socio-economic levels can buy their 
anonymity, and those that are poorer must either relinquish the hope of lifesaving medicines 
or face the potential backlash that may result from disclosing their HIV status. Finally, a 
medical ethical dilemma remains in that a required disclosure of status to a family member or 
to a support group breaches confidentiality regarding "highly sensitive medical information" 
(Macklin,2006:317). Moreover, because ART programmes in other countries do not require 
such disclosure, such as in Malawi (MOH, 2003) and in Zimbabwe (MOHCW, 2003), this 
suggests that drug compliance can be achieved without such a criterion and that individual 
rights are being unnecessarily infringed upon (ibid). 
84Por example, in December 2003, Lorna Mlofane, aT AC volunteer, was murdered in Khayelitsha. 
There is substantial evidence that this was because she was openly HIV positive (TAC, 2004). 
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While research shows that in the MSF Khayelitsha clinics, nobody who meets the 
clinical criteria is ever denied treatment for non-disclosure (Coetzee & Nattrass, 2004), it is 
unclear whether this is the situation across other sites in the province. Moreover, although 
the selection process for ART has generally moved away from outright acceptance or denial 
towards preparing medically eligible patients to become 'treatment-ready' and to comply 
with adherence criteria, the disclosure criterion is still problematic. Some partners note that 
there have certainly been cases of sick AIDS patients who have trouble finding someone they 
trust to disclose to, and this extended process of acquiring a 'treatment buddy' has, in effect, 
denied them lifesaving treatment in a timely manner (Fox & Goemaere, 2006)86. In addition, 
although disclosure is strongly recommended in the policy, in the process of this research it 
became clear that many health care providers have interpreted this as required to allow for 
treatment. The need for health care providers, including counsellors, to adopt an approach of 
flexibility when considering this criterion is critical87• 
For example, Dr. Maartens88 of Groote Schuur hospital emphasizes that: 
"People need to either disclose or join a support group. If somebody has not 
disclosed to anybody they don't well, and they are under enormous stress and are 
isolated, and that is not a good idea. But I think we need to be flexible about it 
because it is problematic with stigma because stigma does still exist but, hopefully, it 
is being broken down slowly. I think [the policy recommendation) is an excellent idea 
as long as it is flexible. " 
Dr. Grimwood89 of ARK further notes that: 
"If someone is completely adamant that they are not going to disclose, you can't hold 
them back from treatment, you just can't do it, it's just a violation ... We try not to 
push that [criterion}, we [rather} try and encourage it. " 
86 Booysen, 2006, personal comm., 20 July; Goemaere, 2006, personal comm., 18 July; Mthathi, 2006, 
personal comm., 17 July. 
8? Booysen, 2006, personal comm., 20 July; Goemaere, 2006, personal comm., 18 July; Grimwood, 
2006, personal comm., 10 July; Hassan, 2006, personal comm., 11 July; Maartens, 2006, personal 
comm., 29 June Naidoo, 2006, personal comm., 7 August. 
88 Maartens, 2006, personal comm., 29 June. 
















In addition, Ms. Hassan90 of the ALP even recommends that: 
"It is enough if you can disclose to your health care worker and the nurse. It is 
important for people to be able to disclose to someone, but if the circumstances 
means that they can't, you can't deny them getting access to treatment because they 
are in a position where they can't tell another family member. I think it will take time 
before people will be able to tell other people. The programme is new ... there is still 
a lot of stigma and discrimination, people still see HIVas a death sentence." 
Moreover, Dr. Goemaere91 of MSF remains ambivalent about this criterion and pertinently notes 
that: 
"The counsellors are judgemental and normative in terms of abiding to the 'rule' [of 
disclosure] and to the text. If [patients] are not ready to disclose to anybody or to 
their partner .... we ask the counsellor to help them identifY someone in a support 
group. [Strongly recommending disclosure] is [however] an issue. It's a whole 
debate. While one of the building blocks of HIV treatment is confidentiality; we are 
proactively anti-confidential... in what we practice here." 
While further research is required to better understand what factors might prevent 
disclosure, how those on treatment in the public sector overcame their fears of disclosure and 
how many people are being excluded from this programme because of this policy, it is also 
important to establish consistent and, thus, equitable disclosure policies in both the public and 
private health care systems. That is, when enrolling patients on treatment, a strongly 
recommended disclosure guideline should be integrated for consideration within private care 
practice as well, or this criterion should be removed from public sector implementation of 
ART altogether. 
In addition, the patient selection criteria of literacy and lack of alcohol and drug 
dependency also deserve further consideration. While these are all extremely important 
factors that could potentially disrupt adherence to ARVs, it is important to consider available 
evidence that demonstrates this as well as alternative approaches to outright exclusion. In the 
Western Cape, misuse of alcohol and drugs is implicated in 18.4% of all deaths in the 
province, indicating the widespread level of alcohol and drug abuse (Cummins, 2002). 
Moreover, illiteracy and high levels of alcohol and drug abuse are pervasive in lower socio-
90 Hassan, 2006, personal comm., 11 JUly. 



















economic classes92 implying that this ART programme is potentially not adequately reaching 
the poorest of the poor because of its selection policy. This seems particularly ironic given 
the established literature demonstrating the link between increased vulnerability to 
HIV/AIDS and lower socio-economic status (Fenton, 2004; Head, 1992; Kalichman et at., 
2005; McCoy, 2003; Stillwaggon, 2002 & 2003). That is, in effect, the very populations that 
most likely need ART are least likely to be able to access it. 
While the Western Cape ART programme conducts referrals to detoxification and 
rehabilitation centres for people actively abusing alcohol and/or drugs, with the view that 
they should first be treated for substance abuse before they can begin ARV treatment 
(Provincial Administration Western Cape, 2004), it is highly possible that many of these 
patients will never be able to benefit from ART. For one, there are not many substance abuse 
treatment centres in the province93 . In addition, some partners observe that these patients 
often get lost from the health system or may greatly deteriorate in health or even die in the 
time it takes to undergo extensive drug rehabilitation94 • Moreover, when considering the 
PGWC's ability to adequately deal with alcohol and substance abuse in the context of 
provision of ART, Dr. Grimwood of ARK95 notes: 
"The [health} system cannot see it ... Ifyou are not geared/or it as a system, you can't 
read it .. .It is bizarrely, you know, quiet [on this issue}. It is scary that we kind 0/ walk 
with blinkers on." 
In a context like the Western Cape, where research has shown how rampant drug and alcohol 
abuse is (Cummins, 2002; HSRC, 1998; SACENDU & MRC, 2006), it is imperative to 
consider some other policy options. 
92 The legacy of apartheid persists in the new South Africa with 70% of the poor living in the former 
apartheid homelands (Castro-Leal, 1999). These populations are most vulnerable to alcohol and drug 
abuse which has been shown to be associated with poverty and higher levels of unemployment and 
crime (HSRC, 1998). Moreover, South Africa's matriculation results show poor performance overall 
and continued marked differences along racial and socio-economic lines (May, 1998). 
93 Goemaere, 2006, personal comm., 18 July; Grimwood, 2006, personal comm., 10 July; Hassan, 2006, 
personal comm., 11 July; Maartens, 2006, personal comm., 29 June; Mthathi, 2006, personal comm., 
17 July. 
94 Goemaere, 2006, personal comm., 18 July; Grimwood, 2006, personal comm., 10 July; Mthathi, 2006, 
personal comm., 17 July; Wood, 2006, personal comm., 7 August. 











The WHO's Guidance on Ethics and Equitable Access to HIV Treatment and Care 
(2004b:29) clearly states that special efforts are required to ensure equal ART access for the 
poor including "making the process of selection of patients as egalitarian as possible". 
Moreover, WHO (2004b:30) advises that: 
"Making presumptions about patients' inability to adhere to treatment and then 
denying them access to ART is ethically problematic because denials based on 
unreliable predictions amount to unfair discrimination, and non-adherence is 
associated with conditions of greatest need." 
While a research project at the Chris Hani Baragwanath hospital in Johannesburg 
suggested that socio-behavioural factors such as alcoholism can be impediments to adherence 
(Schneider, 2003), with ART scale-ups being a recent event globally, there is still very little 
evidence that demonstrates that criteria such as drug and alcohol abuse anticipate future 
adherence with any reliability (WHO, 2004b). In the absence of evidence-based criteria for 
future adherence, decisions to exclude potential patients from the ART programme are 
subject to stereotyping and discriminatory practices (Macklin, 2006; Ware et at., 2005). 
For example, Dr. Goemaere96 observes that: 
"[In Khayelitsha}, there is definitely discrimination [by health care staff] towards 
those people [who abuse alcohol and drugs}. [In the first year}, there was an initial 
agreement that there were 180 [treatment} slots and, at that time, we had a whole 
selection committee with scoring sheets ... scoring people to give priority [for ARV 
provision}. In that time, an alcoholic, male, single -- no way. It was completely 
discriminatory but it was linked to a limited number of slots. Nowadays, supposedly, 
we are not limited by the number of treatment slots [anymore}. It is a real question 
but [discrimination} is happening ... .Anyone who has serious substance abuse, and is 
known to have that abuse, there is no institution to come out to. There. There is a 
serious mistake. And counsellors are extremely judgemental." 
Moreover, there is evidence suggesting that health care providers have limited success in 
predicting adherence generally (Wood, 2005), and such selection processes become 
problematic for public sector programmes aiming to achieve universal access (Myer & El-
Sadr, 2004; Von Schoen Angerer et al., 2001). Critically, provider assessments of 'treatment 
readiness', or lack thereof, should not be used as a means to ration access to treatment 
(Gebrekristos et al., 2005). 
















Even if it was possible to accurately detennine future adherence amongst people who 
abuse alcohol and drugs, the principles of fairness and right to equality would require special 
measures to improve adherence and retention in care in patients that encountered difficulties -
- as opposed to excluding them from the programme (Myer & EI-Sadr, 2004; WHO, 2004b). 
Dr. Slingers of the PGWC notes that doctors at ART sites should, at the very least, use every 
resource available to them to facilitate adherence support in such cases97 • For example, in 
other countries it has been shown that HIV-infected Injecting Drug Users who receive 
comprehensive care with respect to drug dependence, mental health and HIV, usually adhere 
to their treatment plans as well as other patients (WHO, 2004b). While this would require a 
more resource intensive model of care, the psycho-social community support system being 
implemented in Gugulethu or the Patient Advocate model developed by ARK offer a 
potential starting point (see pages 43-44 for details on these models). Moreover, a co-
ordinated multi-sector approach, particularly between the Department of Social Services and 
the DOH, is essential to have success in this area98 • While the provincial government is not 
expected to immediately ensure access to everyone in the scale-up of ART, the Constitution 
(Government of South Africa, 1996: Chapter 2, Article 27 (2» requires the state, with respect 
to the right to health care services, to: 
"Take reasonable legislative and other measures, within its available resources, to 
achieve the progressive realisation of [this) right." 
That is, the provincial government is obliged to put in place a plan, with accompanying time-
line and allocated resources, to ensure that the above-mentioned barriers to accessing the 
ART programme are addressed and equity is, ultimately, achieved. 
Finally, the links between the prOViSIOn of ART and treatment of opportunistic 
infections ofTB (and MDR-TB) merits attention -- particularly for the Western Cape that has 
the highest rate ofTB in South Africa (Abdullah, 2005a). For example, in Khayelitsha, more 
than half of TB sufferers are co-infected with HIV (WHO, 2003). National and Western 
Cape treatment protocols dictate that someone who presents with co-infection of HI V and TB 
must first be treated for TB before they can begin ART due to the adverse reactions of taking 
97 Stingers, 2006, personal comm., 9 August. 
98 Booysen, 2006, personal comm., 20 July; Cloete, 2006, personal comm., 8 August; Hassan, 2006, 




















both therapies (DOH, 2004; Provincial Administration Western Cape, 2004). This poses an 
extremely difficult challenge for the province in ensuring access to ART in these contexts 
where TB rates are so high, and the need for evidence-based clinical guidelines on the most 
favourable time to initiate ART in TB patients has been identified as a priority (JCSMF, 
2006b). Moreover, Dr. Maartens of Groote Schuur hospital suggests a more nuanced 
approach to dual treatment looking at each individual case by case99. He reflects that: 
"TB is our biggest problem and it is difficult to manage them jointly. There are all 
sorts of problems. It is nuanced and I think that is how [the policy] should be." 
Although outside the scope of this present study, further detailed research in this area is vital. 
Gender Equitable Promotion and Programme Strategies 
Historically, reproductive health services have exclusively targeted women and their 
specialized needs (Cooper et aI., 2004). Furthermore, HIV/AIDS advocacy, prevention and 
treatment efforts have often focussed on reaching women presenting at health services around 
pregnancy (Ipas, 2005). Actively targeting men in HIVI AIDS programmes is critical since 
dominant gender100 norms of masculinity not only subjugate women and girls and increase 
their vulnerabilities to HIV/AIDS, but also endanger men's own sexual and reproductive 
health because of, or even despite, their greater power (Gupta et ai, 2003; Morrell, 2001; 
Peacock & Botha, 2004; Population Council, 2001; Selikow et al., 2002). Abdool Karim 
(2005: 253) defines these gender norms: 
"In most societies women are cast in a subordinate, dependent and passive role 
where the ideal virtues include virginity, motherhood, obedience, and ignorance -
particularly about their bodies. In contradistinction, masculinity is cast in terms of 
aggression, dominance, independence and invincibility, where the key virtues are 
strength, courage and virility." 
99 Maartens, 2006, personal comm., 29 June. 
100 Gupta (2000: 18) defines gender as "the widely shared expectations and norms within a society 
about appropriate male and female behaviour, characteristics and roles. It is a social and cultural 
construct that differentiates women from men and defines the ways in which women and men interact 


















These prevailing gender nonns have shown to detennine both men's and women's 
ability to access health care services for treatment of HIV/AIDS. In this context, health 
programme strategies must take into consideration gender reiations101 vis-a-vis HIV/AIDS 
programming. For example, research has shown that women's access to health care may be 
limited due to men's control of a woman's finances, mobility and the decision-making 
process as to whether she should seek HIV/AIDS health services (Gupta, 2000; Population 
Council, 2001; UNAIDS, UNFPA & UNIFEM, 2004). Moreover, unless a woman is 
pregnant and referred for HIV I AIDS care through maternal services, gender nonns that 
encourage virginity in women and the popular notion that infection is linked to promiscuity 
could also deter women from accessing services for fear of stigma and discrimination (Gupta, 
2000; UNAIDS, UNFP A & UNIFEM, 2004). Significantly, however, recent studies in South 
Africa indicate that men access HIVI AIDS testing and treatment services later than women, 
viewing this health-seeking behaviour as a sign of weakness (Peacock, 2005). Cultural 
notions of manhood, combined with stigma, a preference to use traditional medicine and 
logistical issues around attending a clinic when employed, have also all been found to be 
barriers to men acknowledging their HIV status and seeking medical treatment (Beck, 2004). 
Moreover, in South Africa, seven out of ten adults accessing ART are women (JCSMF, 
2006b), most of whom are directly referred to ART from maternal services. Similar data is 
also seen at the provincial level across ART sites in the Western Cape (Bekker et ai., 2006; 
Coetzee & Nattrass, 2004; Pienaar et ai., 2006). 
This data points to gender inequity in provision of ART services within the public 
sector in the Western Cape. Dr. Maartens 1 02 of Groote Schuur hospital reflects that: 
101 Agarwal (1994:51) defines gender relations as "the relations of power between women and men 
which are revealed in a range of practices, ideas and representations, including the division of labour, 
roles and resources between women and men, and the ascribing to them of different abilities, 
attitudes, desires, personality traits, behavioural patterns, and so on". 
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"One of the biggest challenges is where are the men? They are just not coming forth 
for care. I think the biggest problem is that our health care messages have further 
stigmatized men and made it virtually impossible for men to access care. The first 
programme that the province supported here was for children. Why are children 
more important than adults? And then the next programme was for their mothers. 
Women and children [seen} as the victims.1fthey are the victims, what are men? The 
perpetrators. Now there are men out there who are perpetrators and there are also 
men out there who are infected and are not rapists or whatever. But, unfortunately, 
the message that has gone out is that men are the problem and women are not." 
Furthermore, in general, clinics are not 'male-friendly' and the majority of health care staff 
are women -- a factor that has shown to further alienate men from accessing VCT and 
treatment services103 . Dr. Goemaerel04 ofMSF observes that: 
"Counsellors are very judgemental. It is dangerous. It is a real issue ... And there is an 
enormous prejudice against males. The health services are run by women ... They are 
making the decisions in terms of inclusions and there is a prejudice against men 
because there is a certain stereotype of men ... The whole picture of men ... is 
absolutely traumatic." 
In addition, in some sites in the Western Cape with huge backlogs, pregnant women 
with low CD4+ counts are given priority and are allowed to "jump the queue" for ART 
services (Abdullah, 2005b). While it is critical that pregnant women obtain ARVs in a 
timeous manner to protect their health and that of their child, this practice does place health 
care providers in an "ethical quandary" vis-a-vis other sick patients already worked up and 
waiting for treatment (Abdullah, 2005b:261). When considering different rationing systems 
Rosen et ai. (2005) conclude that prioritizing treatment and care for pregnant women is an 
extremely effective and efficient strategy but does create a system that reduces equity in 
access. McCoy (2003) goes so far to state that it promotes pregnancy as a means to access 
treatment. That is, targeting women for ART through maternal services prioritizes them over 
men as well as women who are not currently bearing children (Rosen et ai., 2004). While it 
is certainly merited that such an approach would be utilized in an environment of limited 
resources and capacity, as well as in the long-term interests of averting the growing 
103 Booysen, 2006, personal comm., 20 July; Goemaere, 2006, personal comm., 18 July; Maartens, 2006, 
personal comm., 29 June; Mthathi, 2006, personal comm., 17 July; Naidoo, 2006, personal comm., 7 
August. 
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population of HIV/AIDS orphans, as the PGWC begins to expand access to ART, new 
strategies that reach these other populations will need to be employed in an effort to achieve 
equitable and, ultimately, universal access. 
While health services and promotion policies are currently not adequately targeting 
the inclusion of men into ART in the Western Cape, the PGWC warns that the ART 
programme is already operating at full capacity, and that a coordinated outreach effort to 
bring in all eligible patients -- including the missing men -- could flood the system 105. Dr. 
Cloete of the PGWC further explains that: 
"/ think that we are in the business of setting up the health systems in response to the 
needs of the people. We know there is an unmet health need amongst men. Until we 
see models to tell us this is the way to do it we are not going to embark on any fancy 
strategies to get men into the service, until somebody demonstrates to us a good 
model to put our energies and money into. We are struggling just as it is to meet the 
need pitching up at our doorsteps." 
Some informants felt that, despite these resource limitations, given the high prevalence of 
HIV in men in South Africa as well as gender norms that make both men and women 
increasingly vulnerable to HIV/AIDS, the need to actively target men as partners in 
HIV/AIDS prevention messages, VCT and treatment is, nonetheless, critical. Re-orienting 
PMTCT and subsequent ART referrals towards families (UNAIDS, UNFPA & UNIFEM, 
2004), such as in the PMTCT-Plus initiative in Langa, increasing awareness and activism on 
HIV/AIDS amongst men such as with the Men as Partners programmel06, reaching men who 
are already in the hospital system and ensuring that VCT is readily available both within and 
outside the health care system are some key strategies to addressing this gender inequity. 
Further, family-oriented treatment programmes may not only increase the likelihood that men 
use these services but also that all patients adhere to ARV s and are retained in care, therefore, 
leading to better clinical outcomes (Myer & EI-Sadr, 2004). Moreover, the JCSMF (2006b) 
105 Cloete, 2006, personal comm., 8 August. 
106 Driven by the need for a more effective response to HIV/AIDS and violence against women in 
South Africa, EngenderHealth and the Planned Parenthood Association of South Africa (PP ASA) 
established a Men As Partners (MAP) programme. The overall goal of the programme is to increase 
men's involvement in HIV/AIDS related prevention, care and support activities by encouraging men 
to take an active stand against gender-based violence and for gender equality in their personal lives 
















has also recently labelled reaching men as a critical challenge in the ARV roll-out and has 
called on government to urgently develop strategies that will effectively encourage men to 
access HIV / AIDS treatment and care services. 
Recently, a shift has been seen in the Western Cape sites where ARK is working, 
where the percentage of women presenting for this service -- in relation to men -- has 
dropped from 75% to 59%107. Dr. Grimwood of ARK attributes this change to: 
"The fact that the women are getting better, remaining well, getting stronger, getting 
back to work, becoming more financially independent, and the men are becoming 
weaker and realizing that [ART} is something that they can get a hold off. " 
Moreover, the PGWC has just embarked on a respondent-driven sampling research project to 
determine how a community-based platform can more effectively engage men and create a 
demand for health care services 108. In addition, the City of Cape Town DOH has been trying 
to actively target men at taxi ranks in Belville, and will do so later this year in Mitchell's 
Plain (in collaboration with the Department of Transport of the City of Cape Town), as well 
as through STI clinics (traditionally 'spaces' for men) and at four non-clinic VCT centres lO9• 
Nutritional Support 
It is important to note the critical role of nutritional support in an ART programme. 
Numerous studies have demonstrated a more rapid transition from HIV to AIDS in 
malnourished people as well as increased susceptibility to infectious diseases in general 
(Anabwani & Navario, 2005; Chandra, 1996; De Waal & Whiteside, 2003; Fawzi et ai., 
2004; Stillwaggon, 2002; Van Lettow et ai., 2003; Visser, 2005). Moreover, in other 
countries, health outcomes on ART have proven to be sub-standard due to poor nutritional 
status (International HIV / AIDS Alliance, 2002). Sufficient food supplies have shown to be 
both preventative, in that they support healthy immune systems, and remedial, in that they are 
essential for drug treatment to be effective and reduce viral load (ibid). 
107 Grimwood, 2006, personal comm., 10 July. 
108 Cloete, 2006, personal comm., 8 August. 
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While the government of South Africa has plans to provide nutritional support to 
those who need it, through programmes such as the Nutrition Supplementation Programme 
for people living with TB and HIV/AIDS, the extent to which these policies are being 
implemented successfully is questionable (Ndlovu & Daswa, 2006a; TAC, 2006b; TAC & 
ALP,2005). Furthermore, the Operational Plan holds the DOH accountable for provision of 
nutritional supplements for ARV patients, coordinating interdepartmental nutritional 
programmes and developing nutritional training materials (DOH, 2003:82-85). With regards 
to nutritional support for patients on ARV treatment, it (DOH, 2003:82) explicitly states that: 
"The HIV and AIDS care and treatment programme envisages the provision of 
supplement meals to all people with clinical AIDS who are malnourished and are 
eligible for AR Vs, and who do not have access to a secure food supply. Individuals 
with AIDS who are not food insecure, and who receive care and treatment through a 
service point, should be referred to one of the appropriate existing nutritional 
programmes for additional nutritional support, if indicated." 
To date, the Western Cape ART programme has not prioritized the provision of 
nutritional support for all patients on ARVs (Abdullah, 2005b). For one, the PGWC note that 
the administration of the nutrition programme is structurally separate from the ART 
programme and this has led to a challenge of coordination in implementation -- with eligible 
ART patients being referred from ART sites to clinics that offer the nutrition programme! 10 • 
Moreover, Ms. Van Nierkerk, Assistant Director of the Integrated Nutrition Programme of 
the PGWC, observes that while the Nutrition Supplementation Programme budget was 
traditionally geared to target approximately 90% malnourished children and 10% adult TB 
patients, with the advent of ART this ratio of children to adults receiving nutritional 
supplements has shifted in favour of adults -- with approximately a third of ART patients 
currently receiving this service!!!. This, however, has not been accompanied by an 
appropriate increase in budget to allow for this escalating demand in nutritional supportll2. 
This means that not only is there a cap on capacity to provide this service to all ART 
patients that need it, but, in effect, for each adult on ART receiving food supplements, there 
will be a malnourished child who no longer can do so. 
110 Cloete, 2006, personal comm., 8 August; Osler, 2006, personal comm., 30 June; Van Nierkerk, 
2006, personal comm., 14 July. 
111 Van Nierkerk, 2006, personal comm., 14 July. 



















While a policy was developed in 2005 to eliminate the referral system and allow for 
nutritional support for all patients who request it at the actual ARV sites in the Western Cape 
(Abdullah, 2005b), the PGWC note that budgetary and procedural processes are still being 
resolved1l3. Moreover, while the PGWC touts the establishment of the programme at 33 of 
the 44 ART sites, it also reflects that implementation remains challenged by the lack of 
dieticians and nutritionists in the province, persisting poor coordination amongst the 
programmes ("red tape") as well as the fact that the administration of food supplements is 
still not being properly recorded in the registers by doctors at ART sites 114. This makes it 
very hard to determine the effectiveness of this policy to date. Partners note that, in 
practice, this policy is not working at all and in some sites they are relying on the work of 
local NGOs and Community-Based Organisations (CBOs) to provide nutrition to food 
insecure ART patients I 15. In addition, until 2005, MSF itself provided nutritional 
supplements to pre-ART patients in Khayelitsha -- to try and stabilize HIV positive patients 
before beginning treatment -- but no longer does so with the government policy aimed at 
solely targeting patients actually on ARVS I16 . 
With the recent DOH policy framework geanng towards decentralization of the 
PGWC ART programme, the PGWC emphasizes that in order to ensure smoother linkages 
between delivery of ART as well as the nutrition programme (traditionally based at the 
district clinic level), it is essential that ART services are now firmly integrated within district-
level primary health care clinics1I7. With implementation of this strategy pending, an 
examination of how the effectiveness of the nutrition programme to date has affected 
adherence in the Western Cape programme, as well as any positive outcomes in therapy, is an 
important research question. Moreover, the possible implications of this vis-a-vis the 
provision of an equitable and universal programme are critical policy considerations given 
that patients from poorer households who are more likely to be malnourished may have less 
positive health outcomes than patients from more affluent settings. 
113 Van Nierkerk, 2006, personal comm., 14 July. 
114 Osler, 2006, personal comm., 30 June; Van Nierkerk, 2006, personal comm., 14 July. 
115 Goemaere, 2006, personal comm., 18 July; Grimwood, 2006, personal comm., 10 July; Hassan, 2006, 
personal comm., 11 July; Khwaza, 2006, personal comm., 20 July. 
116 Goemaere, 2006, personal comm., 18 July. 


















Health Systems Strengthening 
In post-apartheid South Africa, the government has aimed to develop a more equitable 
national health care system through expanded access within a district-based system of 
primary health care that integrates clinical care with health promotion and disease prevention 
(Benatar, 2004; DOH, 2000). This primary care model places emphasis on the development 
of basic health care programmes such as antenatal care, child health and nutrition, 
immunization, and the "management of communicable disease and the treatment of chronic 
ailments" (DOH, 2000:3). Within such a health care model, numerous scholars emphasize 
the crucial importance of integrating an ART programme firmly within the public health 
primary health care system while strengthening systems for both ART as well as overall 
health care delivery (McCoy et al., 2005; Nattrass & Geffen, 2003; Schneider & Coetzee, 
2003; Stewart et aI., 2004; Stewart & Loveday, 2005; WHO, 2005a). ART programmes have 
even been conceptualized as opportunities for addressing underlying problems and 
transforming the public health system as a whole (Abdullah, 2005b/ 18. 
In this context, scarce human resources and weak health systems, especially 
procurement and supply chain management (PSM) systems1l9 for HIV/AIDS drugs and 
diagnostics, remain some of the key barriers in rolling out ART (Gray, 2005; ITPC, 2006; 
Kober & Van Damme, 2004; Stewart & Loveday, 2005; TAC, 2005c; TAC & ALP, 2005; 
WHO, 2005a). Even though the Western Cape has scaled-up ART effectively, suggesting 
that these potential difficulties have been overcome, the province is still challenged in 
achieving overall health system strengthening at the primary care level12o. While it is 
certainly too soon to measure the effects of ART services on delivery of overall health care 
services, some are more sceptical than others. Dr. Toms of the City of Cape Town 
Department of Health notes that, if anything, it has greatly strained the existing primary 
health care service despite the reduction in morbidity events of HI VIA IDS patients l21 . This is 
discussed more below. 
118 Mthathi, 2006, personal comm., 17 July; Wood, 2006, personal comm., 7 August. 
119 Procurement and Supply Chain Management (PSM) refers to the complicated and intricate process 
of product selection, forecasting, procurement of quality assured drugs and diagnostics in sufficient 
quantities, inventory management, reliable and secure distribution to suppliers and monitoring and 
evaluation ofthe full PSM cycle to ensure rationale use (GF ATM, 2005). 
120 Cloete, 2006, personal comm., 8 August; Mthathi, 2006, personal COffiill., 17 July; Naidoo, 2006, 
personal comm., 7 August; Toms, 2006, personal COffiill., 13 July. 















The Current ART Implementation Model in the Western Cape 
The PGWC has committed itself to integrating the HIV I AIDS programme, including 
the ART programme, into the general public health system by allocating the additional 
resources from this programme into strengthening the health system instead of creating a 
vertical approach to HIV/AIDS service delivery122 (Ndlovu & Daswa, 2006b). While a 
horizontal model has been sought by the provincial government, as a result of the provision 
of ARVs being widely considered by experts as "far more complex than any other primary 
care intervention ever in the history of health care" 123, a strategy of specialized care has been 
utilized to date. Unlike in the primary care model, patients are referred directly from VCT 
sites, antenatal clinics, TB and STI local authority clinics to specialist ARV sites (Abdullah, 
2005b). Moreover, while the national primary health care model essentially aims to empower 
services at the district level, because of the complexities of providing ART and the lack of 
capacity often at the local authority level, the PGWC has subsumed control 124 of the 
management of these services throughout the province125. As such, this set-up, while deemed 
necessary by the PGWC and partners to allow for the rapid scale-up of this service126, is in 
contradiction with a national vision of a district-based and driven system. Furthermore, 
agreements between PGWC and local authorities on this process are still being delicately 
defined. On reflecting on this model, Dr. Goemaere127 of MSF raises concerns about the 
centralization of ART provision within the Provincial government-controlled sites, such as at 
hospitals or CHCs, as opposed to at the local authority level clinics, noting that: 
122 A 'vertical' health model refers to developing a specialized service for a given health problem 
using dedicated health workers as compared to a 'horizontal' approach where a general health service 
aims to tackle overall health problems on a wide front and long-term basis (Mills, 2005). 
123 Maartens, 2006, personal comm., 29 June. 
124 To-date, the ART programme is not only financially and administratively managed by the PGWC 
but ART sites are set-up predominantly in PGWC-controlled hospitals (levels one, two and three) as 
well as Community Health Clinics (CHCs) -- as opposed to city-run district level clinics (Cloete, 
2006, personal comm., 8 August). 
125 Boulle, 2006, personal comm., 27 July; Cloete, 2006, personal comm., 8 August; Grimwood, 2006, 
personal comm., 10 July; Mthathi, 2006, personal comm., 17 July. 
126 Boulle, 2006, personal comm., 27 July; Cloete, 2006, personal comm., 8 August; Hassan, 2006, 
personal comm., 11 July; Mthathi, 2006, personal comm., 17 July; Toms, 2006, personal comm., 13 
July. 
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"[Setting up} a centralized [ART} unit within a tertiary-based hospital-- that was the 
worst place to put it actually, and as a result, they were very quickly saturated and 
also started to face adherence problems because it is far away and it is costly .... it is 
very well known that people can not afford to go there on a regular basis because of 
the taxi fares." 
While the PGWC stand firm on the need to have initiated ART in this manner, they do 
wholly recognize these physical constraints posed by the current model 128 • 
Furthermore, the current ART delivery model in the province (coined the "Rolls-
Royce ART service") is also viewed by some as too costly and, thus, as non-sustainable --
diverting additional resources that should be strengthening the overall primary health care 
system into a specialized service for HIV/AIDS. For one, Dr. Goemaere of MSF and Dr. 
N aidoo and Dr. Toms of the City of Cape Town DOH observe that most ART staff positions 
were strategically classified at a senior level (Senior Medical Officers or Principal Medical 
Officers), luring a cadre of health care providers from within the public health system with 
the attractive recruitment packages, and leaving gaping vacancies in other areas of health care 
provision129. While ARK have employed a strategy in the sites they work in of only 
recruiting ART health care providers from private sector or that are in retirement, this 
phenomenon of 'poaching of staff by the PGWC from the general health services is certainly 
perceived across all the sites. Dr. Cioete130 ofthe PGWC fully acknowledges this: 
"Because of the way that we implemented, and we fidly acknowledge that as a 
department, and there is a reason why we did it. We did it fitll willingly knowing what 
we were doing. We implemented it as a vertical model. So because we implemented it 
as a vertical model the impact on other services would be negative. It has dedicated 
people, they don't get involved with the rest of the services, and we are dragging staff 
and training staff from other services into the ARV programme. Maybe if you do a 
very crude analysis at each of the sites you could say that people on ARVs get better 
treatment, and other clients get worse treatment. So all of those things. We are fidly 
aware that if you do an assessment that is what you 'Il find." 
128 Cloete, 2006, personal comm., 8 August. 
129 Goemaere, 2006, personal comm., 18 July; Naidoo, 2006, personal comm., 7 August; Toms, 2006, 
personal comm., 13 July. 














In addition, the current system is doctor-driven and, hence, more costly, and is not 
sustainable if the province is to continue expanding treatment to achieve universal access. 
For example, current modelling of the provincial epidemic -- using the present ART health 
delivery model -- estimates that 42 ART doctors will be needed in Khayelitsha by 2010 if the 
province is to keep up with demandl3l • The POWC as well as partners agree that this model 
is not feasible and that a nurse-driven approach132 must be adopted (Pienaar et a!., 2006)133. 
However, research has shown that, even with the current ART model, the increase in nurses 
since the advent of the ART programme has been inadequate to cope with the demands of 
administering ART as well as tending to the increasing number of AIDS-sick patients 
(Nattrass, 2006a). Moreover, with only 31.5% of all nurses trained in South Africa between 
1996 and 2004 having registered with the South African Nursing Council (Subedar, 2005), a 
huge percentage of trained nurses are being 'lost' from the system -- a factor that could 
greatly impede the province's ability to successfully roll-out a nurse-driven ART programme 
(Nattrass,2006a). Nevertheless, there is now consensus among the POWC and partners that 
it is essential to recruit and retain more nurses within the health system, as well as to broaden 
their scope of practice, in order to ensure the efficient and effective expansion of ART 
(Pienaar et al., 2006). In this context, a failure to invest in nurses sufficiently will seriously 
constrain the province's ability to continue to increase ART provision (Nattrass, 2006a). 
Finally, as a conditionality of the OF A TM grant, and in an effort to have greater 
control over the procurement and supply chain management of HIV/AIDS medicines -- and 
safeguard against stock-outs and theft -- the POWC set up a parallel system comprising a 
separate ARV depot (Abdullah, 2005b; Naimak, 2006)134. This has been highly criticized by 
some who claim that the resources should have been used to strengthen the functioning of the 
Cape Medical Depot that houses all other medicines and diagnostics procured by the DOH, 
instead of unnecessarily building a new infrastructure, hiring new staff and creating more 
bureaucracy to manage the HIV I AIDS treatment programme. While the POWC are firm on 
131 Boulle, 2006, personal comm., 27 July; Goemaere, 2006, personal comm., 18 July. 
132 A nurse-driven model based on WHO's Integrated Management of Adolescent and Adult Illness 
(IMAl) model designed to make ART delivery more effective and efficient in the context of human 
resource shortages should be explored (WHO, 2004c). This model includes a down-shifting oftasks 
from doctors to nurses to community health workers (ibid). 
133 Boulle, 2006, personal comm., 27 July; Cloete, 2006, personal comm., 8 August; Goemaere, 2006, 
personal comm., 18 July; Hassan, 2006, personal comm., 11 July; Naidoo, 2006, personal comm., 7 
August; Slingers, 2006, personal comm., 9 August; Toms, 2006, personal comm., 13 July. 
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the importance of having set up a separate system initially, as the province has gained more 
experience and expertise in the large-scale procurement of HIV/AIDS drugs, there are now 
plans to merge the separate ARV PSM system into the already existing provincial supply 
chain and depot in the next two years 135. 
Some believe that while taking the health systems strengthening approach would have 
meant slower initial delivery, and lower treatment numbers, it would have had multiple 
positive and reinforcing effects on the delivery of all primary health care services -- including 
ART -- in the long-term. Dr. Toms 136 of the City of Cape Town DOH reflects that, in effect: 
"fA vertical approach to HIVIAIDSj is dangerous. It works but at what costs? Then 
children are not getting immunized. You actually unwind a lot of the good work that 
you have been doingfrom the outset. You don 'f ultimately save lives. You save people 
who are HIV positive but you are killing kids with diarrhoea because they can't 
access the service now because there is no staff. Because they all went to the AR V 
programme because they pay more. That is what de facto happened ... The more you 
'verticalize' the programme the more you encourage stigma almost because you are 
making it special and different both amongst patients and health care workers and, of 
course, the guys controlling the funds ... So you see the danger of vertical funding 
becomes more and more again the 'specialness' and now you can zap it, or drive it 
depending on the political changes." 
Persisting Challenges in ART Health System Delivery 
Amidst the challenge of overall health systems strengthening, the POWC is still 
facing a number of obstacles in ensuing effective ART delivery itself. As noted previously, 
the HIV/AIDS ART provincial budget is swiftly reaching its maximum, meaning that there 
will be a cap on infrastructure and staffing as well as the quantity of HIV/AIDS drugs and 
diagnostics that can be purchased, and, thus, patients who can receive ART. Ultimately, the 
enrolment capacity of the programme is a function of the number of staff and any limits in 
this area will preclude the province from reaching more people who are in desperate need of 
ART. Furthermore, the POWC and TAC note that the province continues to struggle to 
recruit the medical staff that it needs to sustain the scaling-up of this programme, particularly 
135 Cloete, 2006, personal comm., 8 August; Slingers, 2006, personal comm., 9 August. 




















III the rural areas (TAC, 2005c)137. Finally, physical infrastructure has shown to be a 
constraint in the effective expansion of ART services at some sites in the province (Abdullah, 
2005b; Bekker et al., 2006; Pienaar et al., 2006). There are also generally too few facilities 
in many areas to effectively cater to the health needs of communities (TAC, 2006b). For 
example, Khayelitsha with a population exceeding 500,000 is only served by three ART 
clinics, whereas the U.N.'s Inter-Agency Standing Committee recommended population to 
clinic ratio would require at least ten (ibid). These factors are all greatly curtailing the ability 
of the Western Cape to achieve universal access to ART. 
A Way Forward: A Decentralised and Integrated Approach 
In light of all these challenges, and in line with the recently-endorsed Comprehensive 
Service Plan for Health Care 2010, the POWC has renewed its priority to effectively 
integrate ART within other primary care services and, thus, achieve overall health systems 
strengthening138• While the vertical approach was vital to the rapid provision of ARVs, and 
to meet external donor's requirements of achieving treatment numbers (Nattrass, 2006a), it is 
now widely agreed that in the medium and long-term these services should be fully integrated 
into the primary health care district-level system and that an integrated continuum of care 
should be provided. Moreover, the POWC and partners note that a number of hospitals and 
sites in the province are already reporting that they are running at full capacity and can't cope 
with the increasing demand for ART139. This has been evidenced by the continuing 
deferment of eligible patients and long waiting times (Pienaar et al., 2006). For example, Dr. 
Ooemaere140 ofMSF observes that: 
"The numbers are a big issue in terms of access [in Khayelitsha). You have to queue 
early morning despite the fact that there are appointments, and now to be admitted 
there, to get a folder number and a specific folder, the appointments are given for in 
three or four months time. [The sites are} saturated. The only possibility is to 
decentralize filrther to existing city clinics -- we have eleven here in Khayelitsha." 
137 Mthathi, 2006, personal comm., 17 July; Slingers, 2006, personal comm., 9 August. 
138 Cloete, 2006, personal comm., 8 August. 
139 Cloete, 2006, personal comm., 8 August; Goemaere, 2006, personal comm., 18 July; Naidoo, 2006, 
personal comm., 7 August; Slingers, 2006, personal comm., 9 August; Toms, 2006, personal comm., 
13 July. 













In this context, the PGWC, in collaboration with the City of Cape Town DOH, have 
developed a new ART model using the analogy of a 'hub-and-spokes' system141 • This is 
beginning to be implemented this year. In this approach, a central hub clinic (the current 
PGWC hospital or CHC ART site) is established in an urban centre with smaller spoke 
district-run clinics spread throughout a defined geographical area. Patients needing ARVs 
and living in a hub's catchment area would be referred to the hub for a treatment readiness 
evaluation, education and drugs. After a period of successful treatment through the hub, 
'green patients' who are stabilized on ARVs with no complications and adherence difficulties 
will be referred back to their local spoke where their care will be managed. Patients will only 
return to the hub for specialized care or to address severe complications that may arise. This 
model is primarily nurse-driven and would move monitoring and care as well as provision of 
ARVs into the district-level primary health care system. Moreover, staffing would be 
strengthened at the local level in this model with the view to have ART fully integrated 
within district-level clinics and, in time, actual ART uptake processed at the clinic level as 
well-- through doctor outreach and, eventually, by nurses142. Only ART patients with special 
needs would then be referred to the hub site. 
Through such an approach to ART, not only will geographical barriers to access be 
removed but stigma around seeking HIV/AIDS treatment and care is likely to be reduced as 
these services are 'normalized' within the context of other health services (Pienaar et ai., 
2006). Most critically, the PGWC and partners agree that the service will now be placed 
where it is needed most -- at the district community level. Only by fully mobilising the 
existing health system -- including at the district level -- can universal access be achieved 
(Loewenson & McCoy, 2004; Schneider, 2003). By the end of 2006, the PGWC and City of 
Cape Town DOH plan to implement this model in nine local authority clinics143 . While two 
of these nine sites aim to expand ART services managed by MSF in Khayelitsha, Dr. 
Goemaerel44 ofMSF reflects that to-date: 
141 Cloete, 2006, personal comm., 8 August; Slingers, 2006, personal comm., 9 August; Toms, 2006, 
personal comm., 13 July. 
142 Please note that there is still disagreement on how to implement this model vis-a.-vis staffing at the 
local clinic level as compared to at the CRC and hospital levels. Some are arguing for full clinical 
teams including ARV specialist doctors to be placed at the local level as opposed to establishing a 
referral system whereby nurses at the clinic level refer patients to the central hub ART site for 
necessary care by ART doctors (Boulle, 2006, personal comm., 27 July; Pienaar et al., 2006). 
143 Cloete, 2006, personal comm., 8 August; Naidoo, 2006, personal comm., 7 August. 















"It has been a fantastic waste of opportunity ... From a technical point of view, we 
need the City service. They have huge capacity and they are dealing with TB and STIs 
which are two very important things [for ARTprovisionj, and they are there." 
With the impending transition towards local ownership of the HIV/AIDS treatment 
programme, the POWC has developed plans to build more infrastructure to support the ART 
scale-up, as well as to better integrate the ART programme with TB services at the local level 
-- in an effort to ensure that both these programmes are more efficient and that effective 
continuum of care is provided to patients 145. A study of both the TB and HIV services in 
Khayelitsha indicated that despite active cross-referrals between both programmes, there 
was unnecessary overlap of activities, duplication of services and under-utilization of staff 
(Coetzee et al., 2004b). In addition, recent research has highlighted that there is a general 
sentiment amongst health care providers that integration of HIV and TB services would 
assist in 'demystifying' the ART programme and further normalizing it within district 
health services (Pienaar et al., 2006:5). As a result, in order to achieve this and optimise 
available financial and human resources, several sites have piloted the integration of HIV 
and TB services. For example, in Hout Bay, the City of Cape Town DOH has effectively 
integrated these services using a nurse-driven approach and generating enduring high TB 
cure rates and positive ART treatment outcomes146. This makes this site an important model 
for other clinics as the province expands this integrated approach. Furthermore, in 
collaboration with ARK, the integration of PMTCT, TB services and paediatric care into 
ART services is also beginning -- forming the second phase of POWC's partnership with 
this N00147. 
145 Cloete, 2006, personal comm., 8 August; Slingers, 2006, personal comm., 9 August. 
146 Naidoo, 2006, personal comm., 7 August. 


















This process of integration aims to ultimately achieve health systems strengthening 
while maintaining ART programme outcomes. Dr. Cloete148 of the PGWC explains: 
"If you take a timeline for integration, we must do integration from the point of view 
of maintaining the outcomes. If you follow that logic, how would this integrated 
programme now start benefiting the rest? By maintaining the outcomes, and what has 
been good about [the ART programme} you can then start spreading it to the other 
[health services]." 
In addition, Dr. Grimwood149 of ARK remains optimistic about this strategy to integrate and 
move ART into a more horizontal approach: 
"I think it is very possible to have a fully integrated system with time. What we need 
to do is to understand [that you have to} get the systems in place and get clinicians, 
patients and clinic staff familiar with process and StlifJ so you can then, therefore, 
start incorporating it; But there are certain things you have to do [first). It's like a 
recipe that you need to follow. If you don't follow it, you end up with problems. If 
you try and get that process embedded in how you manage it, than you can take it 
anywhere." 
Significantly, partners note that this call to integrate ART more effectively within the 
existing primary health care system has paved the path for a historical and unprecedented 
collaboration between the City of Cape Town and PGWC. This marks the beginning of a 
new kind of partnership between government at different levels, and many hope it will 
inform such cooperation in other areas of Health. 
148 Cloete, 2006, personal comm., 8 August. 



















Within the context of a burgeoning HIV/AIDS pandemic, access to ARV treatment 
remains one of the most pertinent goals in mitigating the impact of this disease on people 
infected and affected by HIV/AIDS and, ultimately, in halting its spread. While ART is 
widely available in developed countries, access to treatment remains inadequate in low and 
middle income countries. Currently, it is estimated that only 20% of people who need ART 
in the developing world have access to it. Moreover, most resource-poor countries are 
struggling to implement treatment programmes in the face of numerous infrastructure and 
systems barriers as well as socio-economic inequalities. 
In South Africa, a history of oppression, social disenfranchisement, the migrant labour 
system and poverty have contributed to the spread of the epidemic with estimated adult 
prevalence rates of 18.8% and antenatal prevalence rates of 30.2%. One of the worst affected 
countries in the world, South Africa continues to have the highest number of people living 
with HIV estimated at 5.5 million within a general population of 47.43 million. Alarmingly, 
HIVI AIDS is also now the primary cause of death in the nation. Within such a bleak context, 
access to life-saving ARVs has become critical, not only to meet public health goals of 
halting the further spread of the epidemic and to reducing morbidity events among PL WHA, 
but also to safeguard the rights and welfare of individuals, families and communities at large. 
Amidst national, regional and global advocacy calling for access to ARV treatment, 
combined with falling HIV/AIDS drugs prices and increasing funding by bilaterals and 
multilaterals, the Western Cape Province has been in the forefront of making treatment 
available to those who need it. Long before a national policy for HIVI AIDS treatment was in 
place, the PGWC courageously pioneered implementation of PMTCT in 1999, and expanded 
this in 2001 to providing ART to the broader community in select pilot sites -- making the 
project the first to use ARVs in government health facilities outside the context of clinical 
trials. Moreover, the PGWC had the foresight to cultivate partnerships with donors such as 
MSF and the Desmond Tutu HIV Centre, as well as other academic and research institutions, 
allowing the province to gain expertise in administration of ARVs while vital research on 
implementation was being conducted. When the national government finally announced the 
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PGWC already had a wealth of experience and expertise in implementation to draw from. 
Since 2004, the PGWC has successfully scaled-up ART provision throughout the 
province. It is considered to be a highly effective and successful programme as evidenced by 
its capacity to quickly and effectively treat a substantial number of PL WHA, while yielding 
continuing positive health outcomes in patients and measurable reductions in AIDS-related 
morbidity and mortality. By December 2005, it was estimated that 55.7% of people that need 
ART in the province had access to it as compared to a national average of 10% for South 
Africa. Within South Africa, this programme has laid the basis for the rest of the country to 
follow suit. Within the global activist and donor environment, the Western Cape Province 
has demonstrated to the international community that the use of ARVs at primary care level 
in resource-constrained settings is feasible, affordable and replicable. 
This research has shown that there are a number of key factors that have contributed 
to the success of the PGWC's ART programme. Firstly, the Western Cape Province has 
historically stronger health systems in place than most other provinces. As such, it was able 
to speedily initiate ART provision where the infrastructure exists. In addition, the HIV 
epidemic in the Western Cape Province is at an earlier stage than in other provinces with a 
provincial antenatal prevalence rate of 15.7% -- almost half the national average. This, 
combined with the epidemic's predominant concentration in the urban areas, allowed the 
PGWC to swiftly target urban centres achieving high coverage rates due to the lower 
numbers of people that need ART in the Western Cape -- as compared to other provinces. 
This may present a challenge for provinces whose infrastructure is not as well developed and 
whose populations are largely rural such as in KwaZulu-Natal. 
Secondly, the province'S head-start in administering ARVs through the PMTCT 
programme and, later, in pilot government-run sites has been cited as the cornerstone of the 
Western Cape's success in scaling-up. Important lessons in ARV provision, developing 
guidelines and managing case loads were drawn from this initial experience. 
Thirdly, this dissertation has shown how key partnerships with NGOs, academic and 
research institutions and, most importantly, donors, have allowed the Western Cape Province 
to forge new ground, conduct vital research and speedily expand coverage. The PGWC's 












Fourthly, when considering the continuing positive health outcomes in patients on this 
programme, this research has shown that the strategies used in the province to ensure 
adherence to medications and retention in care have been central to this success. While there 
are numerous patient-centred adherence support models currently being implemented in the 
province, they all boast successful patient outcomes. Some of these models are more 
resource-intensive than others and further research is still required to determine the most 
feasible and cost-effective approach to support the further expansion of ART in the province. 
Importantly, the role ofTAC in treatment literacy for ARV patients and for the community at 
large has been attributed as pivotal to the province's continuing high adherence rates and, 
thus, successful health outcomes. 
Finally, the leadership and management model of the PGWC has been heralded as a 
best practice by all partners. This model has fostered a sense of inclusiveness, partnership 
and joint accountability in implementation of ARV treatment provision. In particular, Dr. 
Fareed Abdullah, former Deputy Director General and Head of the AIDS programme in the 
Western Cape Province, was praised by most informants for his brave leadership and was 
perceived as the force behind the programme's standing success. 
While there are many best practices that can be gleaned for other provinces from this 
case study, this dissertation has shown that some important challenges persist in the medium 
and long-term even in the Western Cape. In particular, with national commitments to the 
progressive achievement of socio-economic rights and, thus, universal access to ART, 
ensuring equitable and timeous access to everyone who is medically eligible for ART 
remains a key obstacle and is an essential determinant of the ultimate success of the 
programme. Moreover, in order to effectively address issues in equity of access, and expand 
coverage, a wider strengthening of health systems is required. 
This research has identified a number of policy and implementation gaps that could 
hinder the realization of the goal of universal access. While there were a limited number of 
treatment slots during the pilot phase of the ART programme -- necessitating a triage 
approach to implementation -- as the programme now expands towards universal access, this, 
in theory, should no longer be a constraint. However, the reality on the ground is that ART 
sites are at full capacity and are still unable to consider all patients equitably. Moreover, the 
















number of patients that can be enrolled on ART next year if this budget is not swiftly 
increased by national government and through other donors. Nonetheless, the PGWC 
remains confident that budgetary issues will not constrain the continuing expansion of ART 
in the province. In this context, as the PGWC enters its second phase of expansion, with 
plans for decentralization and broader health systems strengthening, the gaps in achieving 
equitable access generated from this research become of the utmost importance. 
This dissertation has identified several challenges for the Western Cape Province in 
achieving equitable and, ultimately, universal access. Firstly, with a limited number of ART 
sites mainly concentrated in the urban areas, geographical access to HIV/ AIDS treatment 
remains a barrier for communities living far away, particularly in the rural areas. Until the 
PGWC is able to effectively decentralize provision of ARVs, the current policy dictates that 
transport issues to ART sites should be co-ordinated and resolved through the PGWc. To 
date, this has not been implemented. Thus, this dissertation recommends that appropriate 
guidelines to enact this policy provision are developed. In addition, this research found 
concerns over access barriers of prisoners in the province as well as of patients who move 
back and forth between the Eastern Cape and Western Cape. 
Secondly, the patient selection criteria that consider lack of disclosure and the abuse of 
alcohol and drugs as constraints to treatment-readiness were also found to be problematic in 
ensuring equitable access. It was found that in a number of ART sites, the strongly 
recommended disclosure criterion was seen as a requirement, resulting in patients often 
accessing ART very late or, sometimes, too late. An approach of flexibility has been 
recommended when considering disclosure. In addition, within the context of private 
practice having no disclosure criterion, this research recommends that equitable and, thus, 
consistent policies vis-a-vis disclosure are adopted for both public and private practice. 
Furthermore, while there are legitimate concerns regarding the effects of alcohol and drug 
abuse on ensuring adherence to medications and continuity of care, this research has found 
that patients that are referred to detoxification or rehabilitation centres often get lost from the 
system or die due to the limited support services in this area. In line with WHO, this 
dissertation recommends that additional support services are instituted in time to address such 












Thirdly, the current ART programme has been challenged to reach men effectively, 
given that the majority of ART patients are women referred through maternal services. Some 
infonnants felt that the PGWC was not adequately implementing health promotion strategies 
that would draw men into clinics. Moreover, persisting and traumatic stereotypes of men by 
clinic staff also appear to be posing as a barrier to access. This research recommends that a 
strategy be implemented to more effectively involve men in HIV/AIDS programming and to 
ensure that more men are fast-tracked to ART through the general hospital or clinic system in 
the way that pregnant women are with the PMTCT programme. In addition, approaches to 
target women that are not pregnant are needed as the PGWC continues to expand ART. 
Finally, it is widely accepted that adequate nutrition is an essential component to 
achieving successful health outcomes on ART. This research shows that while the PGWC 
has a policy in place for provision of nutritional supplements, this has not been prioritized nor 
thoroughly integrated within the ART services, and the policy's effectiveness to date remains 
questionable. This has enonnous repercussions vis-a-vis provision of an equitable and 
universal programme given that the poorest of the poor are most likely to be food insecure. 
This dissertation recommends that implementation of the provision of nutritional support is 
re-vitalized as well as prioritized within the PGWC's plans to decentralize and integrate 
ART. 
Access to ARVs is a matter of life or death for PLWHA, so the choice of rationing 
systems that the PGWC utilizes in the scale-up of ART, such as selection of sites, patient 
selection criteria and targeting women through maternal services, are critically important. 
Moreover, government must put measures in place to address these constraints posed by 
policy decisions to expand ART -- building capacity in other areas to ensure universal access 
over time, and revising policies as appropriate to guarantee the progressive realization of the 
rights of all people who need ART. 
Furthennore, this research shows that it is critical that treatment access is expanded in 
a way that strengthens the health system's capacity to provide ART as well as comprehensive 
primary health care services in a sustainable and equitable manner. The PGWC's vertical, 
doctor-driven and hospital and CHC-based approach to ART implementation, while deemed 
necessary for the speedy scale-up of the programme, is now seen by stakeholders as too 
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approach has not contributed to overall health systems strengthening as yet and has been 
perceived by some as having drained the general health services. The PGWC's recently-
endorsed strategy to move implementation of ART to the district-based level, and firmly 
integrate this within existing TB and other general health services, offers much hope to the 
ultimate realization of equitable and universal access as well as overall health systems 
strengthening. 
Finally, in order to ensure that existing disparities in wealth and health are not further 
perpetuated and aggravated, the ART programme should move beyond the purely biomedical 
approach to adequately address social determinants, such as poverty, alcohol and substance 
abuse and gender relations, that could hinder access to ART as well as yield negative health 
outcomes. In line with the PGWC's current approach, this would, critically, involve the 
down-shifting and effective integration of ART within the district level health services, and 
would require a renewed commitment to working with other sectors to address these barriers. 
Only by adopting a multi-sectoral health activism that tackles both the systems in delivery as 
well as the broader political and socio-economic constraints, will the roll-out of ART in the 
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Health. 
Dr. Pren Naidoo (August 7, 2006): Director ofHNIAIDS and TB of the City of Cape Town 
Department of Health. 
Implementing Partners 
Dr. Eric Goemaere (July 18, 2006): Head of Mission of Medecins Sans Frontieres (Doctors 
without Borders) in South Africa. 
Dr. Ashraf Grimwood (July 10, 2006): Executive Director of Absolute Return for Kids 
(ARK) in South Africa, an international (U.K.-based) NGO. 
Ms. Anita Jason (July 10,2006): Patient Advocate Programme Manager of Absolute Return 













Professor Robin Wood (August 7, 2006): Director of the Desmond Tutu HIV Centre, Institute 
for Infectious Disease and Molecular Medicine, University of Cape Town and a Professor of 
Medicine. 
A eadem iesiClin icians 
Dr. Gary Maartens (June 29,2006): Clinical pharmacologist, founder of the adult HIV clinic 
at Groote Schuur Hospital and lecturer at the University of Cape Town. 
Dr. Andrew Boulle (July 27, 2006): Researcher at the Infectious Diseases and Epidemiology 
Unit, University of Cape Town. 
Civil Society Partners and ARV Roll-Out Monitoring Organisations 
Ms. Sipho Mthathi (July 17, 2006): General Secretary of the Treatment Action Campaign 
(TAC). 
Ms. Fredalene Booysen (July 20, 2006): Provincial Organizer of the Western Cape 
Treatment Action Campaign (TAC) Provincial Office. 
Ms. Ntombozuko Khwaza (July 20, 2006): Treatment Project Co-ordinator of the Western 
Cape Treatment Action Campaign (T AC) Provincial Office. 
Ms. Fatima Hassan (July 11, 2006): Attorney and former Deputy Head of the AIDS Law 











The Workings of the HIV Retrovirus and Antiretroviral Therapy 
In order to understand the enormous impact of ART on individuals' lives and, thus, on 
the public health system, it is critical to comprehend the workings of the Human 
Immunodeficiency Virus (HIV) and how ART suppresses it. HIV is a retrovirus that affects 
the immune system in numerous ways leading to its ultimate disintegration and the on-set of 
Acquired Immune Deficiency Syndrome (AIDS) (Morris & Cilliers, 2005; Stevenson, 2003). 
Within the first weeks of infection there is a high level of virus replication that is 
subsequently followed with a viral load decrease as the immune system begins to respond to 
the virus (Morris & Cilliers, 2005). As a result, people living with HIV often remain healthy-
looking for the first years of infection and it can take on average eight to ten years before the 
onset of AIDS (ibid). 
The human immune system operates in a multitude of ways (Stevenson, 2003). It 
comprises of lymphoid organs, such as tonsils, the spleen and bone marrow, and lymph 
containing white blood cells that circulate in the body via the lymph vessels and the blood 
circulation system. These white blood cells include a host of different types of cells, chiefly 
lymphocytes, of which there are two key types: B cells and T cells. B cells produce 
antibodies and attach to a foreign invading body (also known as an antigen) to mark it for 
destruction by other immune cells. T cells can not only mark antigens but can also destroy 
them and this includes the CD4+ T cells that are in the forefront of HIV / AIDS research of the 
HIV virus and its pathogenesis. These CD4+ T cells alert B cells to start making antibodies, 
activate other T cells and immune system scavenger cells called macrophages, and influence 
which type of antibody is produced. There are also other T cells known as the CD8+ cells 
that attack and destroy antigen-infected cells. All these lymphocytes circulate the lymph and 
circulatory systems looking for antigens to protect the host body from. Lymphoid organs 












HIV lIorks hy affecting the lfllfllune system at many ditferent le,els, Firstly, HIV 
directly infe~ts the hody's C04' T lymphocyte8 (1."hidl is a di rect receptor tor the virus). 
leading to a shorter li fc span of the cell and its ultimate demh (Stevenson. 2003), In time. this 
leads to a complete depletion of one's CD4' cell count greatly compromising thc body's 
immune system and leaving the person extremely vulnerable to opfX'rtunistic infections. 
Typically, ARV protocols dictate that when C[)4-'- cdls reach 200 cells/mm3 or below, or if 
the person is showing health indic3tors of reaching Stagc IV of HIV di~ea~e, treatment ~hould 
begin (\>,lI10, 2004a), (Figure 17 below depicts IIIV dise~s.c progression including C[)4+ 
cel l, count~ with thc on-set of ART), 
HIV DISEASE PROGRESSION WITH ART 
STAGE; STA.GE 2 STAGE 3 S-'-AGE 4 =:....----:=---==:...... TIME 
VIRAL 
LOAD 
further. HIV infects T cells ~Iong their full life cycle: 1\01 only do~'S it infect activated T cells 
but ~Iso those that are in a resting state as "ell ~s those that are quk'Scent (Stevenson. 2003), 
Secoll<lly. the HIV virus also targets and infects antigen-presenting ce1l8, namely 
lll~crophagcs ~nd dendritic cells. Infection of lll~crophages occurs lll~inly through the CC RS 
co-receptor and although infedcd 1 ~elb greatly outnumbcr infectcd macrophages in HIV 
infected imlividual8, the infCcted macrophage contl;bute8 to proviru> production al great rJtes 
particularly by enhancing furthcr viral di~,cmination to co.t+ T cells (il:>id). Infected 
dendritic cells h3\'c ,hown to have a ~imilar characteri,tic, ,ending ,ignals to T cells that 
increase their replication of the provirus (ibid). ['in ally, observmions h~ve shown that both 
infected ~nd uninfected cells are adversely ~ffectcd by HIV Icadlllg to greater atrophy of the 
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There are currently 00 cures or reliable vaccines for HIV and AIDS. Without AR r. 
the life expectancy of someone living with liIV/AIDS is drastically reduced (Fanner <'I aI., 
200 1: Schneider & Coetzee. 2003; Coetzce N al.. 2004a). AR r works to halt the cscalating 
effccts of HIV viral replication on thc variolls cells comprising thc human immwl<: systcm. 
Fif<"rc 18 below pictorially depicts this important and life-saving proccss. As such, til<: 
advcnt of ART has effcctively transformcd H1V/A1DS from a tenninal discasc into thc realm 
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List of ARV Sites in the Western Cape Province and People on ART, 
June 2006 
'ow Adu lts Childr~n '" Tat. 1 Ad u lts Ch ildre n ' " Academic CompleJ( 
Groo;e &OOJ'""'''P I'" '" 
, 
" 437 "' "e RO<J C'o" Ho"P ' " , V n , 33g 33g 
T~, .. t_Q II,,,,,, .. • ," " "" .''ll 1 '" 
SubWtal " " '" 1.160 '" 1.135 Boland Overberg 
Cer.,; H<:;,p ' ''' , , , ," " m >- oe' I)o"g., H0',,, .. 2·1 , " ,~ " M' (;,. Ix.,.~ " , " '" " m -Ie-"",,,,,, 1·1 , '" '" " ,~ RotooN,,,,, " , " ll>'J 
, 
'" Swol cf)(hr , , , W , " 
Subtotal " 
, 
" .. , "' 1.079 Metro District Health Services 
C,o, .. oad, " " we '" b~[) ~" " 'e " M , ;w Eer"er,'",' " , " 'M , ,. F3I,e B"Y Ho,;p<I>I " , " ,.e , " 0<.<Ju "' I, ' C.;;:;: " , ", 1.477 m ,-H"" 8", CI m; , 'e , ,e, " "" Ilh·"oz; Q ... , " , " m , 1,~ K"",!o",o" " , " 5~2 '" til ' L.r>\p U""o " 'e " ro~ " "'" r,"""pIlucnei«e CHC n , cO ¥lfl " m ","c"" M CHC " , &, 1.'134 ~ un M,';., ~, P"",, C1(: " , "" 1.0:c:l , 1.038 'J(, ' .,.. j (. CHC " , " 1.1:>10 % 1,095 R"tr""' C-IC , , , " , '" RoW" f.\ J'(oc' '" , '" '" , '93 ci<e B. Kh.,." "h. C,-tC " , • 1 Me 1J(J 1,58J cioo'e',o< ~t. 1 , , " , X, Totje"",w " , " Jl ~ , m, We,t'I .. ~ ';':""'-;1, 1 , , , n , 103 
Subtolai "" '" ." 1Q,81g '" 11,465 Metro Institutions 
ce Joo,,,,, ""'...-. '" " C '" 520 
, 5,0 
~ ,Wots ';':J I"nd ~t'" '" " 353 " 'W \~obM.~t'" '" 
, 
" 3M " n, 
Subtotal " 
, 
" 1,243 '" 1,341 South Capel Karoo 
Beoul"" We" ~t'" , , , '" 20 ," Geor"e ~I'" 
" 
, 
" J?2 " 3~3 Koyon, CO , '" ., " 33? Mv, ,...b ... " , " ", " 225 Qucils"""" , C , '" " m P",,, ,,,, b.,,q CHC " '" '" '" '" P-i",_Altooo CH C , , , " , " TI"""b",etl1U CHC , , , W , "~ 
Subtotal " " " 1,242 , .. 1,402 West Coast Win "lands 
Citru , d.1 H",p,,'" , , , '" 
, 
" Ct"".,·,i l. ~II " " "" " .•, M",r e,I,., H",,<,,\aI " " 1,1 "''' " ,w TC Ne""",,, H",,<f'" " C " 581 153 '34 V,ed"",toe<" , , , '03 , " V'Me'"," , , "' , " 











l2l2 i   
i t f  it i  t  ter  r i   l   . 
 
- "'dull" CM<I ' '''' ." oIAI d"I" r  .  c.* ,  p/eM 
Clt c  bctu.r ...,.., to!  
,. 
'" ~ '" ~"" er ... >biQ .... "  " m m r l'!:"'-U '10",,'" ~ .. ~ ,~ , ,., 
b/o /al .. ,~ , 60 ' ln~It> rJ tl)~
c .. .. tt .opt .. • " '" '"..... OmoJ" 11,;",,,,,,,, " " •• Grains .. " '00  -trr ....... 1  " ' .Roe""""" '00 '. S·~ OI"""'". ~
ubIa/iii ~ .. !
tr  ,Irit;1 u'r  r~,.:ef
r  .... -. • , ~  '"" , m " m  ... .,....,.. ,. " '" _ SO)' 1'1""",1;>' ., • Gt. ... ' .. I.' ..:: ~ , , . 1 '" , ~<>" a. 0 .. " " m '  I<h '~ " Ci •• , '" "" ai"""~i'1 <  .. ' O!\Q' Ciooi. " 1ij<  ..  1,1.0 .. pI1 ,'" "'"'   " +18   ~o'  ...  e: " NO  .  " 1 522~ .,,, ,,,, p "" ":: .. Ion " ". ,<:,1.,-,;; I" c ..;c  1) • .. w.;e ,,,,! c ..;c  " " tC<~ Nu ~""" "' " m '" ' '" ~ •• S M~ ,na "1C ..  e.e~ '" VA1 S tr . .... """",1>  , " " "ObI ........ lT ~
,~.. ., .. ~,., w '"' 
bI(){~1 .. " '" '0.11" ... 1  m ,;, rkm G F __ .... , 
" "" " ~"""'."...,IS '1OIl>ftd_tII " .,  ~VlOkI •• _tII ~  '" 
$WIO'''' ~ . . ) .. 1.'.' 
~pO ~fOO 8_ or_, .. " ~ ~ '"() .... ~ _tI .. m "" - ~ • ~ "  '" ~- '" " m 0._ . • " "  p.."" ... .., Ii  , " '" .. '" P.i"'·lII:e~ CHC • n1lI.,,,,r:.t,,,,,,,  " M • ~
Olal.;JI .. " .1 1 '"  •• 1, OU I me/.M 0,,,,,,,,,,~,,,, " ," o."" , ' I 11 m " ,m1.1 .. " .. , .. , ~, , '. • 1·1 '" .. 'M TC o"""., rIoop "" , '" '" '" v ~. .~ " 10J " '\f'.-.d"" ,,, • 
S O ( (~f .. " ,  I . II ~Ol  .  
